<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NCP</journal-id>
<journal-id journal-id-type="hwp">spncp</journal-id>
<journal-id journal-id-type="nlm-ta">Nutr Clin Pract</journal-id>
<journal-title>Nutrition in Clinical Practice</journal-title>
<issn pub-type="ppub">0884-5336</issn>
<issn pub-type="epub">1941-2452</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0884533613486297</article-id>
<article-id pub-id-type="publisher-id">10.1177_0884533613486297</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Commonly Used “Nutrition” Indicators Do Not Predict Outcome in the Critically Ill</article-title>
<subtitle>A Systematic Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ferrie</surname><given-names>Suzie</given-names></name>
<degrees>MNutrDiet, APD, CNSD</degrees>
<xref ref-type="aff" rid="aff1-0884533613486297">1</xref>
<xref ref-type="aff" rid="aff2-0884533613486297">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Allman-Farinelli</surname><given-names>Margaret</given-names></name>
<degrees>PhD, APD</degrees>
<xref ref-type="aff" rid="aff2-0884533613486297">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0884533613486297"><label>1</label>Royal Prince Alfred Hospital, Sydney, Australia</aff>
<aff id="aff2-0884533613486297"><label>2</label>University of Sydney, Sydney, Australia</aff>
<author-notes>
<corresp id="corresp1-0884533613486297">Suzie Ferrie, Department of Nutrition &amp; Dietetics, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2050, Australia. Email: <email>suzie.ferrie@sswahs.nsw.gov.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>4</issue>
<fpage>463</fpage>
<lpage>484</lpage>
<permissions>
<copyright-statement>© 2013 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>: In everyday practice, clinicians use a variety of anthropometric, biochemical, and clinical indicators to monitor nutrition therapy, but these have limitations in the critically ill. This systematic review of randomized controlled trials aimed to assess whether commonly used anthropometric, biochemical, and clinical nutrition indicators are predictive of patient outcomes in the critically ill. <italic>Materials and Methods</italic>: A computerized bibliographic search was performed using MEDLINE, EMBASE, and CINAHL from 1950 to December 2012, as well as a citation review of relevant articles. Randomized clinical trials of any nutrition interventions in critically ill patients were included if they reported any nutrition indicator after baseline and any clinically meaningful outcome variables. Information about study quality, setting, and findings was extracted using standardized protocols. Because of the heterogeneity of study characteristics, only a narrative synthesis was undertaken. <italic>Results</italic>: Of 223 studies obtained with the search strategy, 2 independent reviewers identified selected 51 studies meeting the eligibility criteria. These reported indicators such as serum albumin, serum prealbumin (transthyretin), retinol-binding protein, transferrin, and lymphocytes. Thirty studies did not report a significant difference in clinical outcomes. Of the remainder, the number of studies supporting a statistical relationship between outcome and particular nutrition indicators was equal to, or outnumbered by, the studies not supporting such a relationship. <italic>Conclusion</italic>: None of the commonly used nutrition monitoring parameters demonstrated consistent associations with outcome in randomized controlled trials. Development of nutrition indicators other than laboratory tests that are more closely linked to the patient’s clinical progress should be a priority.</p>
</abstract>
<kwd-group>
<kwd>review, systematic</kwd>
<kwd>nutrition assessment</kwd>
<kwd>critical illness</kwd>
<kwd>serum albumin</kwd>
<kwd>prealbumin</kwd>
<kwd>retinol-binding proteins</kwd>
<kwd>transferrin</kwd>
<kwd>lymphocyte count</kwd>
<kwd>body weight</kwd>
<kwd>skinfold thickness</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Assessment of nutrition status in the critically ill continues to be discussed in the literature.<sup><xref ref-type="bibr" rid="bibr1-0884533613486297">1</xref>,<xref ref-type="bibr" rid="bibr2-0884533613486297">2</xref></sup> Once a patient’s admission in the intensive care unit (ICU) extends beyond a few days, however, nutrition <italic>monitoring</italic> becomes important, and this issue has not received as much attention in the critically ill. Many well-documented nutrition assessment parameters (such as Subjective Global Assessment classification<sup><xref ref-type="bibr" rid="bibr3-0884533613486297">3</xref><xref ref-type="bibr" rid="bibr4-0884533613486297"/><xref ref-type="bibr" rid="bibr5-0884533613486297"/>-<xref ref-type="bibr" rid="bibr6-0884533613486297">6</xref></sup> or serum albumin level<sup><xref ref-type="bibr" rid="bibr7-0884533613486297">7</xref></sup>) are excellent prognostic indicators, predicting mortality, morbidity, and length of hospital stay in patients both in and outside the ICU. But these indicators do not change significantly within the timeframe of a short-term response to nutrition therapy, so they are not useful for assessing whether the nutrition provided is optimal. There is a need for indicators of nutrition progress that can be monitored sequentially, where the change in the indicator over time is predictive of an improved outcome.</p>
<p>Monitoring response to nutrition support in the ICU is important because, although it is recognized that nutrition improves outcomes in the critically ill,<sup><xref ref-type="bibr" rid="bibr8-0884533613486297">8</xref>,<xref ref-type="bibr" rid="bibr9-0884533613486297">9</xref></sup> the nutrition requirements of critically ill patients remain unclear and in some areas controversial. For example, even when an accurate evaluation of energy expenditure is possible, opinions differ as to whether it is appropriate to attempt to match this value or to aim for a lower target for nutrition support.<sup><xref ref-type="bibr" rid="bibr10-0884533613486297">10</xref>,<xref ref-type="bibr" rid="bibr11-0884533613486297">11</xref></sup> In addition, recommendations for the protein and micronutrient requirements of the critically ill are not based on high-level evidence. Nutrition monitoring would ideally provide an early indication as to whether an individual patient’s needs are being met optimally, allowing adjustments to be made promptly (rather than waiting for clinical complications such as poor wound healing to indicate that a change is needed).</p>
<p>Many commonly used strategies for monitoring nutrition progress are not easily applicable in the ICU setting. Body weight and anthropometric measures may be altered by short-term body fluid changes; biochemical indices are often deranged in severe illness or trauma; methods that rely on the patient’s response may not be possible due to reduced level of consciousness, neuromuscular blockade, or sedation. Despite this, a recent survey<sup><xref ref-type="bibr" rid="bibr12-0884533613486297">12</xref></sup> indicated that many ICU dietitians continue to rely on parameters such as body weight and serum albumin in their nutrition monitoring of the critically ill; other commonly used “nutrition” indicators include serum prealbumin (transthyretin), nitrogen balance, transferrin, lymphocyte counts or ratios, and C-reactive protein.<sup><xref ref-type="bibr" rid="bibr12-0884533613486297">12</xref></sup> It is unclear whether there is any association between patients’ clinical outcome and an improvement in any of these nutrition indicators, and it appears that this has not been studied in any well-controlled trials previously. Existing high-quality studies in an ICU population, however, may yield data that elucidates this question.</p>
<p>This study aims to use a systematic review methodology to address the following research question: do any of the commonly used nutrition parameters predict clinically meaningful outcomes in the critically ill?</p>
<sec id="section1-0884533613486297" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section2-0884533613486297">
<title>Search Strategy</title>
<p>A search for relevant publications was conducted using MEDLINE, EMBASE, and CINAHL from the earliest date available in each database and without any limitation on language of publication. Date of the last search was December 3, 2012. Additional articles were located from the reference lists of relevant articles. See <xref ref-type="table" rid="table1-0884533613486297">Table 1</xref> for terms used in the search.</p>
<table-wrap id="table1-0884533613486297" position="float">
<label>Table 1.</label>
<caption>
<p>Search Terms Used.</p>
</caption>
<graphic alternate-form-of="table1-0884533613486297" xlink:href="10.1177_0884533613486297-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Search Number</th>
<th align="center">Terms</th>
</tr>
</thead>
<tbody>
<tr>
<td>Search 1</td>
<td>nutrition$.ti OR nutrition$.ab) AND (ICU OR ITU OR critical illness OR critically ill OR critical care OR intensive care OR intensive care units OR sepsis OR bacteremia</td>
</tr>
<tr>
<td>Search 2</td>
<td>nutrition$ assessment OR nutrition$ screening OR nutrition$ risk OR nutrition$ status</td>
</tr>
<tr>
<td>Search 3</td>
<td>outcome$ OR mortality OR stay OR predict$ OR morbidity OR LOS OR wound OR indicat$ OR infectio$ OR complicat$</td>
</tr>
<tr>
<td>Search 4</td>
<td>Clinical Trial/Randomized Controlled Trial.lim</td>
</tr>
<tr>
<td>Search 5</td>
<td>Humans.lim</td>
</tr>
<tr>
<td>Search 6</td>
<td>All Adult (19 plus years).lim</td>
</tr>
<tr>
<td>Search 7</td>
<td>searches 1+2+3+4+5+6</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0884533613486297">
<p>.ti, title; .ab, abstract; .lim, limit. $ used to indicate truncation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section3-0884533613486297">
<title>Selection and Data Extraction</title>
<p>All potentially relevant studies had their titles and abstracts screened for eligibility by 2 researchers independently, using the following criteria: (1) the study had a major focus on nutrition, (2) the study targeted an adult critically ill population, and (3) the study reported on nutrition status or nutrition monitoring. Articles were retrieved if they appeared to be potentially eligible, and 2 researchers then independently examined the full text of each article and then came to consensus on the selection of the articles based on the eligibility criteria. Any disagreements were resolved by discussion. The eligibility criteria were as follows:</p>
<list id="list1-0884533613486297" list-type="order">
<list-item><p>Study had a randomized design.</p></list-item>
<list-item><p>Study population was an adult ICU population as defined by Doig et al.<sup><xref ref-type="bibr" rid="bibr13-0884533613486297">13</xref></sup></p></list-item>
<list-item><p>Study reported at least one of the “nutrition” indicators in use by ICU dietitians<sup><xref ref-type="bibr" rid="bibr12-0884533613486297">12</xref></sup> at more than 1 time point during the study (ie, baseline and any later time point).</p></list-item>
<list-item><p>Study reported on clinically significant outcomes, that is, some measure of how the patient feels, functions, or survives (such as mortality, length of stay, infectious complications).</p></list-item>
</list>
<p>Studies were excluded from the review if they were not randomized, focused on a non–critically ill population, included children, or did not report clinically meaningful outcomes or currently used “nutrition” indicators. See <xref ref-type="fig" rid="fig1-0884533613486297">Figure 1</xref> for details of this process of article selection.</p>
<fig id="fig1-0884533613486297" position="float">
<label>Figure 1.</label>
<caption>
<p>Study selection process. ICU, intensive care unit; RCT, randomized controlled trial.</p>
</caption>
<graphic xlink:href="10.1177_0884533613486297-fig1.tif"/>
</fig>
</sec>
<sec id="section4-0884533613486297">
<title>Data Synthesis</title>
<p>Each study was reviewed to assess whether changes in the nutrition indicators in the separate arms of the study were related to the outcomes of the study. Since lack of a significant relationship between nutrition indicator and outcome may be a consequence of the failure of the intervention (rather than a failure of the indicator), the focus of this review was on studies in which a significant difference in outcome was demonstrated.</p>
<p>Due to the heterogeneity in study design and outcomes reported by the studies, undertaking a meta-analysis was not appropriate. A narrative analysis was performed, describing the study design, study population, intervention, and the relation between any “nutrition” indicators reported and outcomes of interest. In extracting the data, study quality was assessed by both researchers independently. Quality was assessed on the basis of previously published criteria as described by Doig et al,<sup><xref ref-type="bibr" rid="bibr13-0884533613486297">13</xref></sup> Graf et al,<sup><xref ref-type="bibr" rid="bibr14-0884533613486297">14</xref></sup> and Heyland et al.<sup><xref ref-type="bibr" rid="bibr15-0884533613486297">15</xref></sup> These identify the limitations of each study using the following questions: Were the selection criteria, randomization and blinding methods, treatment protocols, outcomes, and any cointerventions described clearly and objectively defined with sufficient detail? Were groups comparable at baseline? Was intent-to-treat analysis performed? Was follow-up complete? Each study was scored by the researchers independently, and the results of higher and lower quality studies were compared.</p>
</sec>
</sec>
<sec id="section5-0884533613486297" sec-type="results">
<title>Results</title>
<p>Using the search process described above, 223 studies remained once duplicates were removed. Of these, 51 studies were found that met the inclusion criteria, that is, they were randomized trials in an ICU population that reported on both outcomes and nutrition indicators. None was published before 1992. All of the studies are listed in <xref ref-type="table" rid="table2-0884533613486297">Table 2</xref>.<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref><xref ref-type="bibr" rid="bibr17-0884533613486297"/><xref ref-type="bibr" rid="bibr18-0884533613486297"/><xref ref-type="bibr" rid="bibr19-0884533613486297"/><xref ref-type="bibr" rid="bibr20-0884533613486297"/><xref ref-type="bibr" rid="bibr21-0884533613486297"/><xref ref-type="bibr" rid="bibr22-0884533613486297"/><xref ref-type="bibr" rid="bibr23-0884533613486297"/><xref ref-type="bibr" rid="bibr24-0884533613486297"/><xref ref-type="bibr" rid="bibr25-0884533613486297"/><xref ref-type="bibr" rid="bibr26-0884533613486297"/><xref ref-type="bibr" rid="bibr27-0884533613486297"/><xref ref-type="bibr" rid="bibr28-0884533613486297"/><xref ref-type="bibr" rid="bibr29-0884533613486297"/><xref ref-type="bibr" rid="bibr30-0884533613486297"/><xref ref-type="bibr" rid="bibr31-0884533613486297"/><xref ref-type="bibr" rid="bibr32-0884533613486297"/><xref ref-type="bibr" rid="bibr33-0884533613486297"/><xref ref-type="bibr" rid="bibr34-0884533613486297"/><xref ref-type="bibr" rid="bibr35-0884533613486297"/><xref ref-type="bibr" rid="bibr36-0884533613486297"/><xref ref-type="bibr" rid="bibr37-0884533613486297"/><xref ref-type="bibr" rid="bibr38-0884533613486297"/><xref ref-type="bibr" rid="bibr39-0884533613486297"/><xref ref-type="bibr" rid="bibr40-0884533613486297"/><xref ref-type="bibr" rid="bibr41-0884533613486297"/><xref ref-type="bibr" rid="bibr42-0884533613486297"/><xref ref-type="bibr" rid="bibr43-0884533613486297"/><xref ref-type="bibr" rid="bibr44-0884533613486297"/><xref ref-type="bibr" rid="bibr45-0884533613486297"/><xref ref-type="bibr" rid="bibr46-0884533613486297"/><xref ref-type="bibr" rid="bibr47-0884533613486297"/><xref ref-type="bibr" rid="bibr48-0884533613486297"/><xref ref-type="bibr" rid="bibr49-0884533613486297"/><xref ref-type="bibr" rid="bibr50-0884533613486297"/><xref ref-type="bibr" rid="bibr51-0884533613486297"/><xref ref-type="bibr" rid="bibr52-0884533613486297"/><xref ref-type="bibr" rid="bibr53-0884533613486297"/><xref ref-type="bibr" rid="bibr54-0884533613486297"/><xref ref-type="bibr" rid="bibr55-0884533613486297"/><xref ref-type="bibr" rid="bibr56-0884533613486297"/><xref ref-type="bibr" rid="bibr57-0884533613486297"/><xref ref-type="bibr" rid="bibr58-0884533613486297"/><xref ref-type="bibr" rid="bibr59-0884533613486297"/><xref ref-type="bibr" rid="bibr60-0884533613486297"/><xref ref-type="bibr" rid="bibr61-0884533613486297"/><xref ref-type="bibr" rid="bibr62-0884533613486297"/><xref ref-type="bibr" rid="bibr63-0884533613486297"/><xref ref-type="bibr" rid="bibr64-0884533613486297"/><xref ref-type="bibr" rid="bibr65-0884533613486297"/>-<xref ref-type="bibr" rid="bibr66-0884533613486297">66</xref></sup> Of these, 30 did not show any significant difference in clinical outcome between the control and intervention groups. As the aim was to find parameters that predict improved outcomes, these studies were not examined further.</p>
<table-wrap id="table2-0884533613486297" position="float">
<label>Table 2.</label>
<caption>
<p>Results of Systematic Review.</p>
</caption>
<graphic alternate-form-of="table2-0884533613486297" xlink:href="10.1177_0884533613486297-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Reference</th>
<th align="center">Patients</th>
<th align="center">Intervention</th>
<th align="center">Outcomes</th>
<th align="center">Difference</th>
<th align="center">Nutrition Indicators</th>
<th align="center">Difference</th>
</tr>
<tr>
<th align="left" colspan="7">Studies With Significant Improvement in Both Outcomes and Nutrition Indicators</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bauer et al,<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref></sup> 2000</td>
<td>n = 120 ICU patients requiring EN</td>
<td>Bolus EN with supplemental PN vs bolus EN with placebo</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin days 4, 7, 14, and 21</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>Intervention 31.2 (18.5) days vs control group 33.7 (27.7) days, <italic>P</italic> = .0022</td>
<td>Serum prealbumin days 4, 14, and 21</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum prealbumin day 7</td>
<td>Intervention 0.15 (0.06) vs control group 0.14 (0.06) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td>RBP days 4, 14, and 21</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infections</td>
<td>NS</td>
<td>RBP day 7</td>
<td>40.9 (29.3) vs 36.5 (23.5) mg/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Days on inotropes</td>
<td>3.8 (4.3) days vs 4.4 (7.2) days, <italic>P</italic> = .0001</td>
<td>Transferrin days 4, 7, 14, and 21</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CRP days 4, 7, 14, and 21</td>
<td>NS</td>
</tr>
<tr>
<td>Fuentes-Orozco et al,<sup><xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref></sup> 2008</td>
<td>n = 44 severe acute pancreatitis ICU</td>
<td>Glutamine PN vs standard PN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum albumin day 10</td>
<td>Intervention 26.9 (5.1) vs control group 23.1 (6.2) g/L, <italic>P</italic> = .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Total serum protein day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td>Total serum protein day 10</td>
<td>63.9 (10.0) vs 57.0 (11.9) g/L, <italic>P</italic> = .03</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>9 of 22 intervention patients vs 16 of 22 control patients, <italic>P</italic> = .03</td>
<td>Lymphocytes day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Surgical Reinterventions</td>
<td>2.3 (0.57) reinterventions vs 3.1 (0.47), <italic>P</italic> = .03</td>
<td>Lymphocytes day 10</td>
<td>1.41 (0.43) vs 1.06 (0.64), <italic>P</italic> = .04</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>WCC day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>WCC day 10</td>
<td>11.43 (6.18) vs 14.87 (4.88), <italic>P</italic> = .04</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CD4 day 5</td>
<td>0.85 (0.43) vs 0.49 (0.29), <italic>P</italic> = .003</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CD4 day 10</td>
<td>0.79 (0.31) vs 0.57 (0.37), <italic>P</italic> = .03</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CD8 day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CD8 day 10</td>
<td>0.53 (0.29) vs 0.37 (0.17), <italic>P</italic> = .03</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CRP day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CRP day 10</td>
<td>52.04 (31.9) vs 95.27 (60.9) mg/L, <italic>P</italic> = .005</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>IL-6 day 10</td>
<td>65.90 (64.08) vs 113.61 (80.78), pg/mL <italic>P</italic> = .03</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>IgA day 10</td>
<td>407.27 (114.33) vs 321.41 (159) mg/dL, <italic>P</italic> = .01</td>
</tr>
<tr>
<td>Garcia-de-Lorenzo et al,<sup><xref ref-type="bibr" rid="bibr18-0884533613486297">18</xref></sup> 1997</td>
<td>n = 69 septic patients requiring PN</td>
<td>Control high protein (A) vs BCAA high protein (B) vs BCAA standard protein (C)</td>
<td>Mortality</td>
<td>9 of 22 group A patients vs 2 of 25 group B patients vs 5 of 22 group C patients, <italic>P</italic> &lt; .03</td>
<td>Serum prealbumin day 3</td>
<td>Group A 0.096 (0.01) vs group B 0.11 (0.01) vs group C 0.10 (0.01) g/L, <italic>P</italic> &lt; .004</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum prealbumin day 7</td>
<td>0.11 (0.01) vs 0.16 (0.02) vs 0.15 (0.01) g/L, <italic>P</italic> &lt; .04</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin day 11</td>
<td>0.12 (0.02) vs 0.13 (0.01) vs 0.16 (0.02) g/L, <italic>P</italic> &lt; .04</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>RBP days 3, 7, and 11</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance days 3, 7, and 11</td>
<td>NS</td>
</tr>
<tr>
<td>He et al,<sup><xref ref-type="bibr" rid="bibr19-0884533613486297">19</xref></sup> 2004</td>
<td>n = 78 severe acute pancreatitis</td>
<td>PN with glutamine vs standard PN vs IV fluids</td>
<td>Mortality</td>
<td>0 of 20 glutamine PN patients and 3 of 21 standard PN patients vs 10 of 23 control patients, <italic>P</italic> &lt; .01</td>
<td>Weight day 14</td>
<td>Glutamine PN 67.5 (15.92) and standard PN 68.6 (14.58) vs control group, 58.1 (11.63) kg, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>Glutamine PN 25.3 (7.60) days and standard PN 28.6 (6.90) days vs control 39.1 (10.60) days, <italic>P</italic> &lt; .01</td>
<td>Serum albumin day 14</td>
<td>36.8 (4.57) and 35.7 (4.62) vs 30.1 (4.53) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Complications</td>
<td>4 of 20 and 11 of 21 patients vs 21 of 23 control patients, <italic>P</italic> &lt; .01</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Pancreatic infection</td>
<td>0 of 20 patients vs 5 of 21 vs 8 of 23, <italic>P</italic> &lt; .01</td>
<td/>
<td/>
</tr>
<tr>
<td>Iovinelli et al,<sup><xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref></sup> 2007</td>
<td>n = 24 COPD requiring mechanical ventilation</td>
<td>PN with LCT/MCT lipid vs PN with LCT</td>
<td>Mortality</td>
<td>NS</td>
<td>Weight days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td>Triceps skinfold days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Failed extubation</td>
<td>NS</td>
<td>Mid-arm muscle circumference days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Speed of ventilator weaning</td>
<td>LCT/MCT lipid 52 (36) hours vs LCT lipid 127 (73) hours, <italic>P</italic> &lt; .05</td>
<td>Serum albumin days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes days 5, 10, and 15</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>T4/T8 ratio day 15</td>
<td>LCT/MCT lipid 2.0 (0.2) vs LCT lipid 1.8 (0.2), <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td>Kaur et al,<sup><xref ref-type="bibr" rid="bibr21-0884533613486297">21</xref></sup> 2005</td>
<td>n = 100 malnourished patients with peritonitis having laparotomy</td>
<td>Postoperative early EN (fed) vs wait for bowel activity and oral diet (control)</td>
<td>Mortality</td>
<td>NS</td>
<td>Loss of weight in ICU</td>
<td>Fed 1.07 vs control group 2.79 kg, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Mid-arm circumference day 3, 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Major complications</td>
<td>6 of 50 fed patients vs 12 of 50 control patients, <italic>P</italic> &lt; .05</td>
<td>Handgrip strength day 3</td>
<td>15.26 (2.63) vs 13.64 (1.98) kg, <italic>P</italic> = .001</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Sepsis score</td>
<td>4.76 (1.30) vs 5.60 (1.15), <italic>P</italic> &lt; .05</td>
<td>Handgrip strength day 7</td>
<td>18.05 (2.37) vs 16.40 (2.43) kg, <italic>P</italic> = .001</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Recovery of gut motility</td>
<td>3.36 (0.75) days vs 4.4 (1.02) days, <italic>P</italic> &lt; .0001</td>
<td>Handgrip strength at discharge</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 3</td>
<td>24.1 (5.4) vs 22.9 (3.7) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 7</td>
<td>25.6 (5.2) vs 22.0 (3.5) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes days 3 and 7</td>
<td>NS</td>
</tr>
<tr>
<td>Liu et al,<sup><xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref></sup> 2011</td>
<td>n = 100 resection of colorectal or gastric cancer</td>
<td>PN with growth hormone and octreotide vs standard PN</td>
<td>Hospital LOS</td>
<td>Intervention 12.9 (4.4) days vs control group 16.7 (6.2) days, <italic>P</italic> &lt; .05</td>
<td>Serum prealbumin day 3</td>
<td>Intervention 0.23 (0.12) vs control group 0.18 (0.08) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum prealbumin day 5</td>
<td>0.25 (0.14) vs 0.21 (0.07) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Complications</td>
<td>0.9 per patient vs 1.6 per patient, <italic>P</italic> &lt; .05</td>
<td>Serum prealbumin day 7</td>
<td>0.27 (0.15) vs 0.24 (0.11) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>11 of 50 intervention patients vs 22 of 50 control patients, <italic>P</italic> &lt; .05</td>
<td>Serum albumin day 3</td>
<td>32.72 (2.15) vs 29.23 (1.91) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>SIRS</td>
<td>10 of 50 patients vs 18 of 50 patients, <italic>P</italic> &lt; .05</td>
<td>Serum albumin day 5</td>
<td>37.31 (3.14) vs 34.15 (2.75) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Tumor recurrence</td>
<td>NS</td>
<td>Serum albumin day 7</td>
<td>38.91 (4.23) vs 35.49 (3.26) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance day 7</td>
<td>−4.5 (5.6) g vs −8.8 (12.5) g, <italic>P</italic> = .008</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 3</td>
<td>2.31 (0.34) vs 1.95 (0.28) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 5</td>
<td>2.48 (0.65) vs 2.31 (0.41) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 7</td>
<td>2.64 (0.76) vs 2.42 (0.51) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Fibronectin day 3</td>
<td>2.41 (0.41) vs 1.96 (0.32) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Fibronectin day 5</td>
<td>2.72 (0.61) vs 2.43 (0.43) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Fibronectin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>IGF-1 day 3</td>
<td>105.2 (35.4) vs 28.1 (24.7) ng/mL, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>IGF-1 day 7</td>
<td>111.3 (38.6) vs 30.1 (25.3) ng/mL, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td>Lu et al,<sup><xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref></sup> 2011</td>
<td>n = 50 elective resection of colon or gastric cancer</td>
<td>Glutamine-containing PN vs standard PN (same total protein)</td>
<td>Postoperative complications</td>
<td>0 of 25 intervention patients vs 4 of 25 control patients, <italic>P</italic> = .037</td>
<td>Serum prealbumin day 7</td>
<td>Intervention 0.21 (0.049) vs control group 0.18 (0.045) g/L, <italic>P</italic> = .039</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance day 7</td>
<td>4.8 (3.6) vs 2.3 (2.1) g, <italic>P</italic> = .048</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>CRP day 7</td>
<td>16.7 (11.8) vs 35.2 (24.8) mg/dL, <italic>P</italic> = .013</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>WCC day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Hemoglobin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Urea day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Creatinine day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Bilirubin day 7</td>
<td>NS</td>
</tr>
<tr>
<td>Singh et al,<sup><xref ref-type="bibr" rid="bibr24-0884533613486297">24</xref></sup> 1998</td>
<td>n = 43 peritonitis</td>
<td>Postoperative early EN vs IV fluids until bowel activity and oral diet</td>
<td>Mortality</td>
<td>NS</td>
<td>Nitrogen balance day 4</td>
<td>1.2 (0.1) vs −11.6 (2.5) g, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Nitrogen balance day 7</td>
<td>5.1 (0.7) vs 1.2 (0.1) g, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>8 of 21 patients vs 22 of 22 patients, <italic>P</italic> &lt; .05</td>
<td/>
<td/>
</tr>
<tr>
<td>Tiengou et al,<sup><xref ref-type="bibr" rid="bibr25-0884533613486297">25</xref></sup> 2006</td>
<td>n = 30 acute pancreatitis requiring EN</td>
<td>Semi-elemental EN vs polymeric EN</td>
<td>Hospital LOS</td>
<td>Semi-elemental 23 (2) days vs control group 27 (1) days, <italic>P</italic> = .006</td>
<td>Loss of weight by day 7</td>
<td>Semi-elemental 1.3 (1.1) vs control group 2.4 (0.0), <italic>P</italic> = .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>CRP day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td>Wischmeyer et al,<sup><xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref></sup> 2001</td>
<td>n = 31 severe burns</td>
<td>EN with IV glutamine vs EN with control IV amino acid solution</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum prealbumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum prealbumin day 14</td>
<td>Intervention 0.17 (0.04) vs control group 0.11 (0.01) g/L, <italic>P</italic> &lt; .04</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Transferrin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Number of surgeries</td>
<td>NS</td>
<td>Transferrin day 14</td>
<td>1.60 (0.14) vs 1.09 (0.11) g/L, <italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Positive blood cultures</td>
<td>NS</td>
<td>CRP day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Gram-negative bacteremias</td>
<td>1 of 12 intervention patients vs 6 of 14 control patients, <italic>P</italic> = .04</td>
<td>CRP day 14</td>
<td>59.8 (13.8) vs 108.1 (13.8) mg/L, <italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td>Xu et al,<sup><xref ref-type="bibr" rid="bibr27-0884533613486297">27</xref></sup> 2006</td>
<td>n = 60 after gut cancer surgery</td>
<td>Preoperative immunonutrition EN vs standard EN</td>
<td>Hospital LOS</td>
<td>Intervention 9 (3.2) days vs control 12 (3.7) days, <italic>P</italic> &lt; .05</td>
<td>Weight loss by day 7</td>
<td>Intervention 1.41 (1.80) g vs control 3.81 (1.87) kg, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>2 of 30 patients vs 8 of 30 patients, <italic>P</italic> &lt; .05</td>
<td>Serum prealbumin day 7</td>
<td>No levels reported, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Noninfectious complications</td>
<td>NS</td>
<td>Transferrin day 7</td>
<td>No levels reported, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Fistula</td>
<td>0 of 30 patients vs 1 of 30 patients, <italic>P</italic> &lt; .05</td>
<td>CD4/CD8 ratio day 7</td>
<td>2.10 (0.51) vs 1.62 (0.52), <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<th align="left" colspan="7">Studies With Significant Improvement in Outcomes but Not Nutrition Indicators</th>
</tr>
<tr>
<td>Battistella et al,<sup><xref ref-type="bibr" rid="bibr28-0884533613486297">28</xref></sup> 1997</td>
<td>n = 60 multiple trauma</td>
<td>PN without lipid vs PN with lipid</td>
<td>Hospital LOS</td>
<td>27 (16) days without lipid vs 39 (24) days with lipid, <italic>P</italic> = .03</td>
<td>Nitrogen balance day 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>18 (12) days vs 29 (22) days, <italic>P</italic> = .02</td>
<td>CD4/CD8 ratio day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>15 (12) days vs 27 (21) days, <italic>P</italic> = .01</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Pneumonia</td>
<td>13 of 27 patients vs 22 of 30 patients, <italic>P</italic> = .05</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Line sepsis</td>
<td>5 of 27 patients vs 13 of 30 patients, <italic>P</italic> = .04</td>
<td/>
<td/>
</tr>
<tr>
<td>Beier-Holgersen et al,<sup><xref ref-type="bibr" rid="bibr29-0884533613486297">29</xref></sup> 1999</td>
<td>n = 60 major GI surgery</td>
<td>Preoperative oral supplement vs placebo</td>
<td>Total postoperative complications</td>
<td>8 of 30 intervention patients vs 19 of 30 control patients, <italic>P</italic> = .009</td>
<td>Cell-mediated immunity</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>2 of 30 patients vs 14 of 30 patients, <italic>P</italic> = .0009</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Anastomotic leak</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>Déchelotte et al,<sup><xref ref-type="bibr" rid="bibr30-0884533613486297">30</xref></sup> 2006</td>
<td>n = 114 ICU patients requiring PN</td>
<td>PN with glutamine vs PN with proline</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum prealbumin day 3, 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>RBP days 3 and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Nitrogen balance days 3 and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Patients with complications</td>
<td>Intervention 24 of 58 patients vs 34 of 56 patients, <italic>P</italic> &lt; .05</td>
<td>PINI score days 3 and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infections per patient</td>
<td>0.45 vs 0.71 infections per patient, <italic>P</italic> &lt; .05</td>
<td/>
<td/>
</tr>
<tr>
<td>Falcão de Arruda et al,<sup><xref ref-type="bibr" rid="bibr31-0884533613486297">31</xref></sup> 2004</td>
<td>n = 23 patients with brain trauma needing ICU and EN</td>
<td>EN with glutamine and probiotics vs standard EN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin days 4 and 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>Intervention 10 (5–20) days vs control group 22 (7–57) days, <italic>P</italic> &lt; .01</td>
<td>Total serum protein days 4 and 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>7 (1–15) days vs 14 (3–53) days, <italic>P</italic> = .04</td>
<td>Hemoglobin days 4 and 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infections per patient</td>
<td>1 (0–3) vs 3 (1–5) infections per patient, <italic>P</italic> &lt; .01</td>
<td>Nitrogen balance days 4 and 7</td>
<td>NS</td>
</tr>
<tr>
<td>Goeters et al,<sup><xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref></sup> 2002</td>
<td>n = 144 ICU patients</td>
<td>PN with glutamine vs standard PN</td>
<td>ICU mortality</td>
<td>NS</td>
<td>Serum albumin days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>30-day</td>
<td>NS</td>
<td>Serum prealbumin days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>mortality</td>
<td>11 of 33 intervention patients vs 21 of 35 control patients, <italic>P</italic> &lt; .05</td>
<td>RBP days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>6-month mortality</td>
<td>NS</td>
<td>Transferrin days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>CRP days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td/>
<td>α-1-acid glycoprotein days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>PINI score days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance days 5 and 10</td>
<td>NS</td>
</tr>
<tr>
<td>de Luis et al,<sup><xref ref-type="bibr" rid="bibr33-0884533613486297">33</xref></sup> 2004</td>
<td>n = 90 after head/neck cancer surgery</td>
<td>EN with arginine vs standard EN</td>
<td>Hospital LOS</td>
<td>Intervention 25.8 (15) days vs control group 35 (24.6) days, <italic>P</italic> &lt; .05</td>
<td>Weight day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Serum albumin day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Fistula</td>
<td>5% vs 11%, <italic>P</italic> &lt; .05</td>
<td>Serum prealbumin day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 14</td>
<td>NS</td>
</tr>
<tr>
<td>de Luis et al,<sup><xref ref-type="bibr" rid="bibr34-0884533613486297">34</xref></sup> 2007</td>
<td>n = 72 after head/neck cancer surgery</td>
<td>EN with arginine vs standard EN</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Weight day 12</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Lean body mass day 12</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Fistula</td>
<td>Intervention 2.8% vs control group 18.9%, <italic>P</italic> &lt; .05</td>
<td>Serum albumin day 12</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin day 12</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 12</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 12</td>
<td>NS</td>
</tr>
<tr>
<td>de Luis et al,<sup><xref ref-type="bibr" rid="bibr35-0884533613486297">35</xref></sup> 2009</td>
<td>n = 72 after head/neck cancer surgery</td>
<td>EN with arginine vs standard EN</td>
<td>Hospital LOS</td>
<td>Intervention 24.3 (14) days vs control group 36.1 (27) days, <italic>P</italic> = .036</td>
<td>Serum albumin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Serum prealbumin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Local complications</td>
<td>5.2% vs 17.6%, <italic>P</italic> = .026</td>
<td>Transferrin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Weight day 10</td>
<td>NS</td>
</tr>
<tr>
<td>Theilla et al,<sup><xref ref-type="bibr" rid="bibr36-0884533613486297">36</xref></sup> 2007</td>
<td>n = 100 acute lung injury</td>
<td>EN with EPA, GLA, and antioxidants vs standard EN</td>
<td>Pressure ulcers</td>
<td>15 of 46 intervention patients vs 24 of 49 control patients, <italic>P</italic> &lt; .05</td>
<td>Serum albumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin day 7</td>
<td>NS</td>
</tr>
<tr>
<th align="left" colspan="7">Studies With No Significant Improvement in Outcomes</th>
</tr>
<tr>
<td>Barbosa et al,<sup><xref ref-type="bibr" rid="bibr37-0884533613486297">37</xref></sup> 2010</td>
<td>n = 30 patients with sepsis or SIRS requiring PN</td>
<td>PN with MCT/soy lipid vs PN with MCT/soy/fish oil lipid</td>
<td>Mortality</td>
<td>NS</td>
<td>Cytokines days 1, 2, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>WCC days 1, 2, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Bilirubin days 1, 2, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>Boivin et al,<sup><xref ref-type="bibr" rid="bibr38-0884533613486297">38</xref></sup> 2001</td>
<td>n = 78 general ICU patients</td>
<td>Postpyloric feeding vs gastric feeds with erythromycin</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum prealbumin day 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>Braga et al,<sup><xref ref-type="bibr" rid="bibr39-0884533613486297">39</xref></sup> 2001</td>
<td>n = 257 upper GI cancer surgery</td>
<td>Postoperative EN vs PN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum prealbumin day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>RBP day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Noninfectious complications</td>
<td>NS</td>
<td>Lymphocytes day 8</td>
<td>NS</td>
</tr>
<tr>
<td>Carr et al,<sup><xref ref-type="bibr" rid="bibr40-0884533613486297">40</xref></sup> 1996</td>
<td>n = 30 after gut resection</td>
<td>Early postoperative EN vs wait for bowel activity and oral diet</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Nitrogen balance day 1</td>
<td>Early EN 5.3 (2.7) vs control −13.2 (11.6) g, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infection</td>
<td>NS</td>
<td>Nitrogen balance day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Return of gut function</td>
<td>NS</td>
<td>Weight day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Handgrip strength day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Mid-arm circumference day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Triceps skinfold day 5</td>
<td>NS</td>
</tr>
<tr>
<td>Casas-Rodera et al,<sup><xref ref-type="bibr" rid="bibr41-0884533613486297">41</xref></sup> 2008</td>
<td>n = 44 head and neck cancer surgery</td>
<td>Postoperative EN standard vs arginine only vs arginine + RNA + ω-3</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Weight days 7 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Wound infections</td>
<td>NS</td>
<td>Serum albumin days 7 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Transferrin days 7 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes days 7 and 14</td>
<td>NS</td>
</tr>
<tr>
<td>Cekmen et al,<sup><xref ref-type="bibr" rid="bibr42-0884533613486297">42</xref></sup> 2011</td>
<td>n = 30 ICU patients requiring PN</td>
<td>Standard vs glutamine-containing PN</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum albumin day 14</td>
<td>32.9 (2.8) glutamine vs 28.5 (5.0) g/L control, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Creatinine day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Mortality</td>
<td>NS</td>
<td>Urea day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Complications</td>
<td>NS</td>
<td>Lymphocytes day 14</td>
<td>NS</td>
</tr>
<tr>
<td>Chen et al,<sup><xref ref-type="bibr" rid="bibr43-0884533613486297">43</xref></sup> 2005</td>
<td>n = 30 after GI cancer surgery</td>
<td>Postoperative PN with LCT vs LCT/MCT lipid</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum prealbumin day 7</td>
<td>0.201 (0.015) LCT/MCT vs control 0.150 (0.018) g/L, <italic>P</italic> = .005</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Weight day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Complications</td>
<td>NS</td>
<td>Triceps skinfold day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Mid-arm circumference day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Immune parameters (Ig) day 7</td>
<td>NS</td>
</tr>
<tr>
<td>Day et al,<sup><xref ref-type="bibr" rid="bibr44-0884533613486297">44</xref></sup> 2001</td>
<td>n = 25 neuro-ICU patients</td>
<td>Gastric vs duodenal EN</td>
<td>Aspiration pneumonia</td>
<td>NS</td>
<td>Serum albumin days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Weight change days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td>Dhanraj et al,<sup><xref ref-type="bibr" rid="bibr45-0884533613486297">45</xref></sup> 1997</td>
<td>n = 20 burns</td>
<td>Hospital-made vs commercial EN formula</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Weight gain day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Procedures</td>
<td>NS</td>
<td>Serum total protein day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Graft take</td>
<td>NS</td>
<td>Transferrin day 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 14</td>
<td>NS</td>
</tr>
<tr>
<td>Dvorak et al,<sup><xref ref-type="bibr" rid="bibr46-0884533613486297">46</xref></sup> 2004</td>
<td>n = 17 acute spinal cord injury</td>
<td>Early vs late EN</td>
<td>LOS</td>
<td>NS</td>
<td>Transferrin days 5 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td/>
<td colspan="3"/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td/>
<td colspan="3"/>
</tr>
<tr>
<td>Garcia-de-Lorenzo et al,<sup><xref ref-type="bibr" rid="bibr47-0884533613486297">47</xref></sup> 2005</td>
<td>n = 22 severe burns</td>
<td>PN with olive oil lipid vs MCT/LCT lipid</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Total serum protein day 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Hemoglobin day 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td/>
<td colspan="3"/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Organ dysfunction score</td>
<td>NS</td>
<td/>
<td colspan="3"/>
</tr>
<tr>
<td>Garnacho-Montero et al,<sup><xref ref-type="bibr" rid="bibr48-0884533613486297">48</xref></sup> 2002</td>
<td>n = 72 ICU patients with abdominal sepsis requiring PN</td>
<td>PN with LCT vs LCT/MCT</td>
<td>ICU mortality</td>
<td>NS</td>
<td>Nitrogen balance day 10</td>
<td>14.2 (2.9) MCT group vs control 11.6 (4.0) g, <italic>P</italic> = .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital mortality</td>
<td>NS</td>
<td>RBP day 10</td>
<td>1.7 (1.0) MCT group vs control 0.8 (0.6) g/L, <italic>P</italic> = .0007</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum albumin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilation requirements</td>
<td>NS</td>
<td>Serum prealbumin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Liver enzymes day 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 10</td>
<td>NS</td>
</tr>
<tr>
<td>Gervasio et al,<sup><xref ref-type="bibr" rid="bibr49-0884533613486297">49</xref></sup> 2000</td>
<td>n = 60 multiple trauma</td>
<td>Oxandrolone vs placebo</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum prealbumin day 28</td>
<td>0.305 (0.127) oxandrolone vs 0.230 (0.073) g/L placebo, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum albumin days 7 and 10, 28</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Serum prealbumin days 7 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Urea days 7, 10, and 28</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Creatinine days 7, 10, and 28</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance days 7, 10, and 28</td>
<td>NS</td>
</tr>
<tr>
<td>Hallay et al,<sup><xref ref-type="bibr" rid="bibr50-0884533613486297">50</xref></sup> 2002</td>
<td>n = 36 after esophagectomy</td>
<td>Postoperative glutamine EN vs standard EN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum prealbumin days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>RBP days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Wound dehiscence</td>
<td>NS</td>
<td>CRP days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Total serum protein days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Immune and inflammatory markers (Ig and WC fractions) days 2, 5, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>NS</td>
</tr>
<tr>
<td>Hatton et al,<sup><xref ref-type="bibr" rid="bibr51-0884533613486297">51</xref></sup> 2006</td>
<td>n = 98 acute moderate or severe brain injury</td>
<td>IV insulin-like growth factor and growth hormone infusion vs placebo</td>
<td>Mortality</td>
<td>NS</td>
<td>Nitrogen balance day 15</td>
<td>1.20 (0.84) growth hormone vs −3.90 (0.87) g control, <italic>P</italic> = .0001</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>Jones et al,<sup><xref ref-type="bibr" rid="bibr52-0884533613486297">52</xref></sup> 1999</td>
<td>n = 78 ICU admissions</td>
<td>Glutamine EN vs standard EN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Urea day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>WCC day 5</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Platelets day 5</td>
<td>NS</td>
</tr>
<tr>
<td>Justo Meirelles et al,<sup><xref ref-type="bibr" rid="bibr53-0884533613486297">53</xref></sup> 2011</td>
<td>n = 22 brain injury patients</td>
<td>EN vs PN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin first 5 days</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Nitrogen balance first 5 days</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>CRP first 5 days</td>
<td>NS</td>
</tr>
<tr>
<td>Kearns et al,<sup><xref ref-type="bibr" rid="bibr54-0884533613486297">54</xref></sup> 2000</td>
<td>n = 44 ventilated ICU patients needing EN</td>
<td>Gastric vs small bowel feeding tube placement</td>
<td>Mortality</td>
<td>NS</td>
<td>Weight change</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infection</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>de Ledinghen et al,<sup><xref ref-type="bibr" rid="bibr55-0884533613486297">55</xref></sup> 1997</td>
<td>n = 22 after variceal bleed</td>
<td>Early EN vs wait for oral diet on day 4</td>
<td>Mortality</td>
<td>NS</td>
<td>Nitrogen balance day 4</td>
<td>0.7 (2.5) early EN vs −11.2 (6.7) g control, <italic>P</italic> = .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Nitrogen balance days 7 and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Liver function</td>
<td>NS</td>
<td>Serum albumin days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Serum prealbumin days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Creatinine days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Triceps skinfold days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Weight days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Mid-arm muscle circumference days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Urinary creatinine days 4, 7, and 35</td>
<td>NS</td>
</tr>
<tr>
<td>Lo et al,<sup><xref ref-type="bibr" rid="bibr56-0884533613486297">56</xref></sup> 2005</td>
<td>n = 28 ventilated for respiratory failure</td>
<td>Hypercaloric EN vs standard</td>
<td>Ventilator parameters</td>
<td>NS</td>
<td>Nitrogen balance week 4</td>
<td>0.52 (2.56) hypercaloric vs −1.91 (2.09) g control, <italic>P</italic> = .006</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Hemoglobin week 4</td>
<td>104 (11) hypercaloric vs 114 (14) g/L control, <italic>P</italic> = .017</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>WCC week 4</td>
<td>21.3 (2.6) hypercaloric vs 8.3 (2.4) control, <italic>P</italic> = .014</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Weight week 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin week 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin week 4</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin week 4</td>
<td>NS</td>
</tr>
<tr>
<td>Montecalvo et al,<sup><xref ref-type="bibr" rid="bibr57-0884533613486297">57</xref></sup> 1992</td>
<td>n = 38 ICU patients needing EN</td>
<td>Gastric vs jejunal tube feeds</td>
<td>ICU LOS</td>
<td>NS</td>
<td>Serum prealbumin day 9</td>
<td>0.13 (0.05) gastric vs 0.21 (0.11) g/L jejunal, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Ventilator days</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Fever, shock, antibiotics</td>
<td>NS</td>
<td/>
<td/>
</tr>
<tr>
<td>Qiu et al,<sup><xref ref-type="bibr" rid="bibr58-0884533613486297">58</xref></sup> 2009</td>
<td>n = 65 after liver transplant</td>
<td>Postoperative PN with glutamine vs standard PN vs IV fluids</td>
<td>Hospital mortality</td>
<td>NS</td>
<td>Serum albumin day 9</td>
<td>40.89 (5.67) glutamine vs 33.37 (2.91) g/L oral diet, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>1-year mortality</td>
<td>NS</td>
<td>Serum prealbumin day 9</td>
<td>0.19 (0.06) vs 0.10 (0.02) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>3-year mortality</td>
<td>NS</td>
<td>Transferrin day 9</td>
<td>2.52 (0.45) vs 1.99 (0.39) g/L oral diet, <italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>PNI day 9</td>
<td>41.06 (6.16) vs 36.66 (3.84), <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Total serum protein day 9</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 9</td>
<td>NS</td>
</tr>
<tr>
<td>Riso et al,<sup><xref ref-type="bibr" rid="bibr59-0884533613486297">59</xref></sup> 2000</td>
<td>n = 44 postoperative head and neck cancer</td>
<td>EN with arginine vs standard</td>
<td>Mortality</td>
<td>NS</td>
<td>Lymphocyte count day 4</td>
<td>1.9 (0.6) arginine vs 1.3 (0.5) control, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Lymphocyte count day 8</td>
<td>2.2 (0.4) arginine vs 1.5 (0.6) control, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Major complications</td>
<td>NS</td>
<td>Serum albumin days 1, 4, and 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin days 1, 4, and 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin day 1, 4, and 8</td>
<td>NS</td>
</tr>
<tr>
<td>Watters et al,<sup><xref ref-type="bibr" rid="bibr60-0884533613486297">60</xref></sup> 1997</td>
<td>n = 31 after major abdominal or thoracic surgery</td>
<td>Postoperative immediate feeding vs no feeding for 6 days</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Vital capacity day 6</td>
<td>Worse in intervention group: 1.8 (1.0) early fed vs 2.4 (0.6) L unfed, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>ICU LOS</td>
<td>NS</td>
<td>Body weight day 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Anastomotic leak</td>
<td>NS</td>
<td>Serum albumin days 2, 4, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Postoperative fatigue</td>
<td>NS</td>
<td>Urea days 2, 4, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Postoperative pain</td>
<td>NS</td>
<td>Creatinine days 2, 4, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Postoperative activity</td>
<td>NS</td>
<td>Urinary nitrogen days 2, 4, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Grip strength days 2, 4, and 6</td>
<td>NS</td>
</tr>
<tr>
<td>Wicks et al,<sup><xref ref-type="bibr" rid="bibr61-0884533613486297">61</xref></sup> 1994</td>
<td>n = 24 after liver transplant</td>
<td>Postoperative EN vs PN</td>
<td>Infectious complications</td>
<td>NS</td>
<td>Mid-arm circumference days 1, 3, 5, 7, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Triceps skinfold days 1, 3, 5, 7, and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Biceps skinfold days 1, 3, 5, 7, and 10</td>
<td>NS</td>
</tr>
<tr>
<td>Wiren et al,<sup><xref ref-type="bibr" rid="bibr62-0884533613486297">62</xref></sup> 2002</td>
<td>n = 20 after major gut surgery</td>
<td>Postoperative EN with α-keto-glutarate (KG) vs standard EN</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 6</td>
<td>Worse in intervention: 31.4 (4.4) KG vs 37.4 (2.9) g/L, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum albumin days 1 and 3</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Complications</td>
<td>NS</td>
<td>Serum prealbumin days 1, 3, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Urea days 1, 3, and 6</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Nitrogen balance days 1, 3, and 6</td>
<td>NS</td>
</tr>
<tr>
<td>Wu et al,<sup><xref ref-type="bibr" rid="bibr63-0884533613486297">63</xref></sup> 1995</td>
<td>n = 40 normally nourished or mildly malnourished elderly (&gt;70 years) after gastrectomy</td>
<td>10-day postoperative PN vs IV dextrose</td>
<td>Mortality</td>
<td>NS</td>
<td>Weight days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Anastomotic breakdown</td>
<td>NS</td>
<td>Triceps skinfold days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Mid-arm muscle circumference days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Total serum protein days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Transferrin days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Cell-mediated immunity skin tests days 2 and 14</td>
<td>NS</td>
</tr>
<tr>
<td>Yeh et al,<sup><xref ref-type="bibr" rid="bibr64-0884533613486297">64</xref></sup> 2008</td>
<td>n = 70 upper GI surgery</td>
<td>Perioperative parenteral protein glutamine vs standard</td>
<td>Mortality</td>
<td>NS</td>
<td>Serum albumin day 7</td>
<td>32.1 (4.8) glutamine vs 30.8 (5.2) g/L control, <italic>P</italic> = .015</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Hospital LOS</td>
<td>NS</td>
<td>Serum prealbumin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Anastomotic breakdown</td>
<td>NS</td>
<td>Transferrin day 7</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>WC fractions day 7</td>
<td>NS</td>
</tr>
<tr>
<td>Zhang et al,<sup><xref ref-type="bibr" rid="bibr65-0884533613486297">65</xref></sup> 2007</td>
<td>n = 48 abdominal surgery</td>
<td>IV growth hormone or placebo</td>
<td>Mortality</td>
<td>NS</td>
<td>Cumulative nitrogen balance 7 days</td>
<td>11.37 (16.82) g growth hormone vs −9.11 (17.52) g control, <italic>P</italic> = .0003</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Infectious complications</td>
<td>NS</td>
<td>Fibronectin day 10</td>
<td>104.77 (19.94) growth hormone vs 93.03 (16.03) control, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Fibronectin day 3</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes days 3 and 10</td>
<td>NS</td>
</tr>
<tr>
<td>Zhu et al,<sup><xref ref-type="bibr" rid="bibr66-0884533613486297">66</xref></sup> 2003</td>
<td>n = 40 after major upper GI surgery</td>
<td>Enteral vs parenteral postoperative nutrition</td>
<td>Hospital LOS</td>
<td>NS</td>
<td>Weight loss day 8</td>
<td>PN 2-kg loss vs EN 1-kg loss, <italic>P</italic> &lt; .05</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Triceps skinfold day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum albumin day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Serum prealbumin day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Creatinine day 8</td>
<td>NS</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Lymphocytes day 8</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0884533613486297">
<p>BCAA, branched-chain amino acids; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; EN, enteral nutrition; EPA, eicosapentaenoic acid; GI, gastrointestinal; GLA, γ-linolenic acid; ICU, intensive care unit; IGF-1, insulin-like growth factor 1; IL-6, interleukin-6; IV, intravenous; LCT, long-chain triglyceride; LOS, length of stay; MCT, medium-chain triglyceride; NS, no significant difference between intervention and control groups; PINI, Prognostic Inflammatory and Nutritional Index; PN, parenteral nutrition; PNI, Prognostic Nutritional Index; SIRS, systemic inflammatory response syndrome; WC, white cell; WCC, total white cell count.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The remaining 21 studies all reported significant improvements in clinical outcome. In 9 of these studies, these outcome improvements were not reflected by changes in any of the nutrition parameters that were measured. In the other 12 studies, a variety of nutrition parameters was reported, which variously did or did not reflect the outcome improvements. See <xref ref-type="table" rid="table3-0884533613486297">Table 3</xref> for details of these nutrition parameters. Note that there is considerable overlap between these 2 groups of parameters—that is, many of the parameters were predictive of outcome in one study but not in another. In an attempt to resolve this contradiction, the quality of each study was assessed in case quality weighting might alter the interpretation of the results. Six studies<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref>,<xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref>,<xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref>,<xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref>,<xref ref-type="bibr" rid="bibr30-0884533613486297">30</xref>,<xref ref-type="bibr" rid="bibr35-0884533613486297">35</xref></sup> were rated “true high quality” by the criteria of Doig et al,<sup><xref ref-type="bibr" rid="bibr13-0884533613486297">13</xref></sup> but a similar overlap was seen even within these 6 studies’ results. When a median split was used to divide between higher quality and lower quality studies, there was no significant difference in terms of obtaining a significant result (<italic>P</italic> = .41). On that basis, it was decided that all of the studies would be included in the review, irrespective of quality score.</p>
<table-wrap id="table3-0884533613486297" position="float">
<label>Table 3.</label>
<caption>
<p>Relationship Between Outcomes and Nutrition Parameters, in Studies With Significantly Improved Outcome.</p>
</caption>
<graphic alternate-form-of="table3-0884533613486297" xlink:href="10.1177_0884533613486297-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2">Nutrition Parameters Measured in the Reviewed RCTs<hr/></th>
</tr>
<tr>
<th align="left">Predictive of Improved Outcome</th>
<th align="center">Not Predictive of Improved Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>Body weight at ICU day 7 or 14 or discharge</td>
<td>Body weight at ICU day 5, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 12, 14, or 15</td>
</tr>
<tr>
<td>Nitrogen balance day 4 or 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Lean body mass at day 12</td>
</tr>
<tr>
<td>Handgrip strength day 3 or 7</td>
<td>Mid-arm circumference day 5, 10, or 15</td>
</tr>
<tr>
<td>Serum albumin day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 14</td>
<td>Triceps skinfold day 5, 10, or 15</td>
</tr>
<tr>
<td>Serum prealbumin day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 11, or 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Mid-arm muscle circumference day 5, 10, or 15</td>
</tr>
<tr>
<td>Retinol-binding protein day 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Nitrogen balance at day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 4, 5, 6<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7, 10, or 11</td>
</tr>
<tr>
<td>Transferrin day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Handgrip strength at hospital discharge</td>
</tr>
<tr>
<td>C-reactive protein day 7, 10, or 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Cell-mediated immunity</td>
</tr>
<tr>
<td>Total serum protein day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Serum albumin day 4<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 12, 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 15, or 21<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>Lymphocytes day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Serum prealbumin day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 4<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5, 6<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 12, 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 21<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>WCC day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Retinol-binding protein day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 4<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5, 6<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7, 10, 11, 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 21<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>CD8 day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Transferrin day 4<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 12, 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 15, or 21<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>CD4 day 5 or 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>C-reactive protein day 4<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 10, 14<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 21<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>CD4/CD8 ratio day 7 or 15</td>
<td>Total serum protein day 4, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 7</td>
</tr>
<tr>
<td>IgA day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>Lymphocytes day 3, 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 7, 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 12, 14, or 15</td>
</tr>
<tr>
<td>IL-6 day 10<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>WCC day 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup> or 7</td>
</tr>
<tr>
<td>IGF-1 day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup> or 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>CD8 day 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td>Fibronectin day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup> or 5<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
<td>CD4/CD8 ratio day 5</td>
</tr>
<tr>
<td/>
<td>Fibronectin day 7<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup></td>
</tr>
<tr>
<td/>
<td>Total iron binding capacity</td>
</tr>
<tr>
<td/>
<td>Hemoglobin day 4 or 7</td>
</tr>
<tr>
<td/>
<td>α-1-acid glycoprotein day 5 or 10</td>
</tr>
<tr>
<td/>
<td>PINI score day 3<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, 5, 6<sup><xref ref-type="table-fn" rid="table-fn3-0884533613486297">a</xref></sup>, or 10</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0884533613486297">
<p>ICU, intensive care unit; IGF-1, insulin-like growth factor 1; IL-6, interleukin-6; PINI, Prognostic Inflammatory and Nutritional Index; RCT, randomized controlled trial; WCC, total white cell count.</p>
</fn>
<fn id="table-fn4-0884533613486297">
<label>a</label>
<p>“True” high-quality studies obtained this result.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The results of this process are described in detail below for nutrition parameters that were reported in 3 or more studies and for the parameters reported as commonly used by ICU dietitians.<sup><xref ref-type="bibr" rid="bibr12-0884533613486297">12</xref></sup></p>
<sec id="section6-0884533613486297">
<title>Weight</title>
<p>Three higher quality studies<sup><xref ref-type="bibr" rid="bibr33-0884533613486297">33</xref><xref ref-type="bibr" rid="bibr34-0884533613486297"/>-<xref ref-type="bibr" rid="bibr35-0884533613486297">35</xref></sup> and 1 lower quality study<sup><xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref></sup> identified in this search found no relationship between outcome and weight measured variously on ICU days 5, 10, 12, 14, and 15. Four lower quality studies<sup><xref ref-type="bibr" rid="bibr19-0884533613486297">19</xref>,<xref ref-type="bibr" rid="bibr21-0884533613486297">21</xref>,<xref ref-type="bibr" rid="bibr25-0884533613486297">25</xref>,<xref ref-type="bibr" rid="bibr27-0884533613486297">27</xref></sup> found that weight on ICU day 7 or 14 was predictive of better outcome. In 3 of these studies, the difference in body weight between the intervention and control groups was 1–2 kg.</p>
</sec>
<sec id="section7-0884533613486297">
<title>Nitrogen Balance</title>
<p>Improved nitrogen balance was associated with better outcome in 2 higher quality studies<sup><xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref>,<xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref></sup> and 1 lower quality study.<sup><xref ref-type="bibr" rid="bibr24-0884533613486297">24</xref></sup> In these studies, it was measured on ICU day 4 (in 1 study) and ICU day 7 (in all 3 studies). The difference between groups ranged from 2–10 g/d of nitrogen. No such association was seen in 2 higher quality studies<sup><xref ref-type="bibr" rid="bibr30-0884533613486297">30</xref>,<xref ref-type="bibr" rid="bibr31-0884533613486297">31</xref></sup> and 3 lower quality studies,<sup><xref ref-type="bibr" rid="bibr18-0884533613486297">18</xref>,<xref ref-type="bibr" rid="bibr28-0884533613486297">28</xref>,<xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref></sup> in which it was measured variously on days 3, 4, 5, 6, 7, 10, and 11 of the ICU stay.</p>
</sec>
<sec id="section8-0884533613486297">
<title>Serum Albumin</title>
<p>Of the 10 higher quality studies, 8 measured serum albumin levels, and only 2 studies<sup><xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref>,<xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref></sup> found any association between improved serum albumin level (on ICU day 3, 5, 7, or 10) and improved clinical outcome. Of the 10 lower quality studies, 6 measured serum albumin (on day 3, 7, or 14), and 2 of these<sup><xref ref-type="bibr" rid="bibr19-0884533613486297">19</xref>,<xref ref-type="bibr" rid="bibr21-0884533613486297">21</xref></sup> found an association with improved outcome. Overall, 10 studies<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref>,<xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref>,<xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref>,<xref ref-type="bibr" rid="bibr25-0884533613486297">25</xref>,<xref ref-type="bibr" rid="bibr31-0884533613486297">31</xref><xref ref-type="bibr" rid="bibr32-0884533613486297"/><xref ref-type="bibr" rid="bibr33-0884533613486297"/><xref ref-type="bibr" rid="bibr34-0884533613486297"/><xref ref-type="bibr" rid="bibr35-0884533613486297"/>-<xref ref-type="bibr" rid="bibr36-0884533613486297">36</xref></sup> found no association between outcome and serum albumin level measured variously on day 5, 7, 10, 12, 14, 15, or 21 of the ICU stay. All of these reported a difference of 4–7 g/L in serum albumin level between the control and intervention groups.</p>
</sec>
<sec id="section9-0884533613486297">
<title>Serum Prealbumin (Transthyretin)</title>
<p>Seven of the 10 higher quality studies measured serum prealbumin, and 4 of these<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref>,<xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref>,<xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref>,<xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref></sup> found an association between improved outcome and higher serum prealbumin levels when measured on ICU day 3, 5, 7, or 14. Four of the 10 lower quality studies measured serum prealbumin, and 2 of these<sup><xref ref-type="bibr" rid="bibr18-0884533613486297">18</xref>,<xref ref-type="bibr" rid="bibr27-0884533613486297">27</xref></sup> found a similar association when serum prealbumin was measured on ICU day 3, 7, or 11. Five studies did not find any such association.<sup><xref ref-type="bibr" rid="bibr30-0884533613486297">30</xref>,<xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref><xref ref-type="bibr" rid="bibr33-0884533613486297"/><xref ref-type="bibr" rid="bibr34-0884533613486297"/><xref ref-type="bibr" rid="bibr35-0884533613486297"/>-<xref ref-type="bibr" rid="bibr36-0884533613486297">36</xref></sup> Of the 6 studies that did find serum prealbumin level to be predictive of outcome, only 2 reported differences in serum prealbumin &gt;0.02 g/L between the intervention and control groups.<sup><xref ref-type="bibr" rid="bibr18-0884533613486297">18</xref>,<xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref></sup> In 2 other studies, although the difference between groups was statistically significant, all of the reported serum prealbumin levels were within the normal range for both groups.<sup><xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref>,<xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref></sup></p>
</sec>
<sec id="section10-0884533613486297">
<title>Retinol-Binding Protein</title>
<p>In 2 lower quality studies<sup><xref ref-type="bibr" rid="bibr18-0884533613486297">18</xref>,<xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref></sup> and 1 higher quality study,<sup><xref ref-type="bibr" rid="bibr30-0884533613486297">30</xref></sup> no association was seen between outcome and retinol-binding protein (RBP) measured on ICU day 5 or 10. In 1 higher quality study,<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref></sup> RBP on ICU day 7 was predictive of improved outcome, but despite a statistically significant difference between groups, all of the reported RBP levels were within the normal range.</p>
</sec>
<sec id="section11-0884533613486297">
<title>Transferrin</title>
<p>Two higher quality studies<sup><xref ref-type="bibr" rid="bibr22-0884533613486297">22</xref>,<xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref></sup> and 1 lower quality study<sup><xref ref-type="bibr" rid="bibr27-0884533613486297">27</xref></sup> found an association between outcome and transferrin measured on ICU day 3, 5, 7, or 10. In 1 of the higher quality studies, all of the reported transferrin levels were within the normal range in both the intervention and control groups; in the other, the difference in transferrin level was 0.5 g/L. The lower quality study reported only the direction of the relationship without specifying the actual transferrin levels. Four higher quality studies<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref>,<xref ref-type="bibr" rid="bibr33-0884533613486297">33</xref><xref ref-type="bibr" rid="bibr34-0884533613486297"/>-<xref ref-type="bibr" rid="bibr35-0884533613486297">35</xref></sup> and 2 lower quality studies<sup><xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref>,<xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref></sup> found no relationship between transferrin level and outcome.</p>
</sec>
<sec id="section12-0884533613486297">
<title>Lymphocytes</title>
<p>One higher quality study<sup><xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref></sup> found that lymphocyte count on ICU day 10 was predictive of outcome, although all the reported levels were within the normal range for both groups in the study. Four higher quality studies<sup><xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref>,<xref ref-type="bibr" rid="bibr33-0884533613486297">33</xref><xref ref-type="bibr" rid="bibr34-0884533613486297"/>-<xref ref-type="bibr" rid="bibr35-0884533613486297">35</xref></sup> and 2 lower quality studies<sup><xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref>,<xref ref-type="bibr" rid="bibr21-0884533613486297">21</xref></sup> found no association between outcome and lymphocyte count.</p>
</sec>
<sec id="section13-0884533613486297">
<title>C-Reactive Protein</title>
<p>Three higher quality studies<sup><xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref>,<xref ref-type="bibr" rid="bibr23-0884533613486297">23</xref>,<xref ref-type="bibr" rid="bibr26-0884533613486297">26</xref></sup> found that lower C-reactive protein levels (on ICU day 7, 10, or 14) were predictive of improved outcome. In all of these, there was an approximately 2-fold difference between groups. One higher quality study<sup><xref ref-type="bibr" rid="bibr16-0884533613486297">16</xref></sup> and 2 lower quality studies<sup><xref ref-type="bibr" rid="bibr25-0884533613486297">25</xref>,<xref ref-type="bibr" rid="bibr32-0884533613486297">32</xref></sup> did not find any association between C-reactive protein and outcome.</p>
</sec>
<sec id="section14-0884533613486297">
<title>CD4/CD8 Ratio</title>
<p>Two lower quality studies<sup><xref ref-type="bibr" rid="bibr20-0884533613486297">20</xref>,<xref ref-type="bibr" rid="bibr27-0884533613486297">27</xref></sup> found an association between outcome and CD4/CD8 ratio measured on day 7 or 15 of ICU stay. One lower quality study<sup><xref ref-type="bibr" rid="bibr28-0884533613486297">28</xref></sup> found no such relationship.</p>
</sec>
<sec id="section15-0884533613486297">
<title>Other Commonly Used Parameters</title>
<p>Only 1 identified (lower quality) study<sup><xref ref-type="bibr" rid="bibr21-0884533613486297">21</xref></sup> used grip strength as a measure, finding a 2-kg difference in grip strength between groups that was associated with better outcome when measured on days 3 and 7 of the ICU stay (but not when measured at hospital discharge). Increased total serum protein was found to be predictive of outcome in 1 higher quality study,<sup><xref ref-type="bibr" rid="bibr17-0884533613486297">17</xref></sup> but this relationship was not seen in 1 other higher quality study.<sup><xref ref-type="bibr" rid="bibr31-0884533613486297">31</xref></sup></p>
</sec>
</sec>
<sec id="section16-0884533613486297" sec-type="discussion">
<title>Discussion</title>
<p>This review was conducted to summarize evidence on the relationship between patient outcomes and commonly used nutrition parameters. A rigorous systematic review methodology was used, with studies restricted to those with a randomized design, to minimize the effect of the many potential confounders that have made observational studies on this topic difficult to interpret. For example, many cohort studies do not take into account differing severity of illness or inflammation. One such study compared patients on enteral, parenteral, and dual nutrition in ICU with respect to anthropometric and biochemical indicators and found that serum prealbumin increased only in the dual-nutrition group after 14 days of nutrition support, but patients receiving the different forms of nutrition were not comparable at baseline and had very different distributions of diagnoses.<sup><xref ref-type="bibr" rid="bibr67-0884533613486297">67</xref></sup> A study in head-injured patients found that serum prealbumin, RBP, and nitrogen balance were better in the enterally fed patients compared with those receiving parenteral nutrition, even though they all received the same amounts of energy and protein.<sup><xref ref-type="bibr" rid="bibr68-0884533613486297">68</xref></sup> A prospective cohort study comparing nutrition intake with weight, serum albumin, serum prealbumin, body composition, and lymphocytes in ICU patients found no correlation,<sup><xref ref-type="bibr" rid="bibr69-0884533613486297">69</xref></sup> whereas another<sup><xref ref-type="bibr" rid="bibr70-0884533613486297">70</xref></sup> found significant improvements in serum prealbumin, transferrin, and RBP with nutrition support in a variety of surgical and nonsurgical patients. The results appear to be mixed, and there are no published systematic reviews of ICU cohort or observational studies on this topic.</p>
<p>There were significant inconsistencies in the results of this review, and it is not possible to draw any strong conclusions. There are several reasons why this might be the case. First, although the studies were of nutrition therapy interventions, in many cases, the improved outcomes could have been due to a mechanism other than a direct nutrition one and thus not be associated with any noticeable change in nutrition indicators.</p>
<p>Second, although the studies encompass a wide range of ICU patients and conditions, it should be noted that none of the studies examined in this review were designed to address the clinical question being investigated here. All were randomized controlled trials of some intervention designed to improve outcomes, with nutrition indicators being only a peripheral aspect of the study, measured infrequently and often incompletely reported. This means that even the high-quality studies examined were not an ideal way to assess the relationship between outcomes and nutrition indicators.</p>
<p>Third, the number of included studies was reduced because studies that do not show an improved outcome were not analyzed, since the aim was to find nutrition indicators that predict an improvement in outcome. Studies in which there was no improvement in outcome are unhelpful in this aim and could not be analyzed as there is no way to distinguish between studies in which the indicator correctly predicted a lack of outcome improvement (due to an ineffective intervention) vs studies in which there was a type II error.</p>
<p>However, despite these limitations, the results do raise grave concerns about how meaningful these commonly used nutrition parameters could be in clinical practice, given that they appear to have no consistent association with patient outcomes. Looking at the number and quality of studies supporting (or not supporting) a relationship between outcome and any individual parameter, it is possible to rank the commonly used parameters. In descending order of support from the literature examined, the order is as follows: serum prealbumin, nitrogen balance, RBP, total serum protein, body weight, transferrin, lymphocyte count, and serum albumin level. In the case of serum prealbumin, 5 of the 11 studies reporting a serum prealbumin level found no relationship with outcome. Six of the 11 found the serum prealbumin level to be predictive of outcome, but only 2 of these 6 studies reported a clinically significant difference in serum prealbumin level that would be identifiable in everyday practice. For all of the other commonly used indicators, the number of supportive studies was outnumbered by those that found no relationship with outcome, and a number of the supportive studies reported clinically undetectable differences.</p>
<p>The traditional use of these nutrition parameters has largely been based on their “validation” in studies that are neither randomized nor controlled, and in many cases, they are misapplied if used for short-term monitoring in a critical care setting. For example, the literature on serum albumin includes a large meta-analysis of 90 prospective and retrospective cohort studies (total nearly 300,000 subjects) that found serum albumin level to be a strong independent predictor of poor outcome, associated with mortality, morbidity, ICU length of stay (LOS), hospital LOS, and hospital cost in a dose-dependent fashion.<sup><xref ref-type="bibr" rid="bibr71-0884533613486297">71</xref></sup> This would appear to support the role of serum albumin as a useful indicator of the patient’s progress in the hospital, since it correlates so strongly with meaningful differences in outcome. However, the majority of the 90 studies in the meta-analysis were reporting on the <italic>mortality</italic> predictive power of a <italic>single</italic> serum albumin level, mostly measured at study entry or admission or within the first few days of admission, or prior to surgery or other planned treatment. That is, these studies were not designed to investigate the use of <italic>sequential</italic> serum albumin levels as a parameter for monitoring <italic>nutrition</italic> progress, and therefore the meta-analysis does not constitute support for this practice. In addition, it is not clear whether attempts to manipulate the serum albumin level would have any effect on outcome. The same meta-analysis also looked at the effect of increasing the serum albumin level with the use of intravenous albumin infusion and found that the resulting improved serum level does not equate to an improved outcome. Spontaneous changes in serum albumin occur only slowly and are strongly affected by the acute phase response and compartmental fluid shifts,<sup><xref ref-type="bibr" rid="bibr72-0884533613486297">72</xref></sup> so improvements in serum albumin level may not be obvious in the first few weeks of critical illness even with optimal nutrition support.<sup><xref ref-type="bibr" rid="bibr73-0884533613486297">73</xref></sup> It therefore appears that, although serum albumin has excellent prognostic value when measured before treatment, it is not valid as an indicator of nutrition progress in the short term.</p>
<p>Similarly, total lymphocyte count has a long history as part of nutrition assessment, based on its strong prognostic value. The lymphocyte count decreases as part of the immunologic dysfunction that occurs with malnutrition.<sup><xref ref-type="bibr" rid="bibr74-0884533613486297">74</xref></sup> This results in an increase in the frequency and severity of infection and consequent poorer outcomes. A 4-fold increase in mortality was reported with a total lymphocyte count below normal,<sup><xref ref-type="bibr" rid="bibr75-0884533613486297">75</xref></sup> and lymphocyte count has been incorporated into a number of screening tools.<sup><xref ref-type="bibr" rid="bibr76-0884533613486297">76</xref><xref ref-type="bibr" rid="bibr77-0884533613486297"/>-<xref ref-type="bibr" rid="bibr78-0884533613486297">78</xref></sup> In a critically ill population, however, a reduced lymphocyte count does not have adequate specificity to be useful,<sup><xref ref-type="bibr" rid="bibr69-0884533613486297">69</xref>,<xref ref-type="bibr" rid="bibr79-0884533613486297">79</xref>-<xref ref-type="bibr" rid="bibr80-0884533613486297">80</xref></sup> and there is no evidence to support the use of sequential lymphocyte counts in monitoring a patient’s response to nutrition support.</p>
<p>Body weight is the most commonly used indicator in assessing nutrition status in everyday life, but the confounding effects of fluid retention in critical illness, and its gradual loss in the first few ICU weeks,<sup><xref ref-type="bibr" rid="bibr81-0884533613486297">81</xref></sup> mean that short-term changes in weight will indicate fluid balance rather than nutrition response in this setting. Weight may thus be a valuable parameter to monitor in the ICU, but not for nutrition reasons. Although resolving fluid retention may correlate with improved outcomes, this may be mediated by factors other than nutrition ones and not correlate with nutrition adequacy in a way that allows it to be used as a nutrition monitoring parameter.</p>
<p>Nitrogen balance is widely used for estimating patients’ protein losses, which can help to establish protein requirements, but loss of protein does not appear to correlate clearly with function in critical illness.<sup><xref ref-type="bibr" rid="bibr82-0884533613486297">82</xref>,<xref ref-type="bibr" rid="bibr83-0884533613486297">83</xref></sup> This may explain why nitrogen balance does not consistently predict outcome, limiting its use as a nutrition indicator early in the ICU stay.</p>
<p>Transferrin, too, appears to be unreliable for this purpose, perhaps because of the confounding effect of iron status and inflammatory changes on transferrin level,<sup><xref ref-type="bibr" rid="bibr84-0884533613486297">84</xref></sup> giving inconsistent results when attempting to correlate it with outcome. In this review, only 3 of 9 studies supported such a relationship, and 2 of these 3 reported differences that are smaller than a laboratory’s range of error.</p>
<p>Serum prealbumin level is one of the more widely used parameters examined in this review. It has been popular as a nutrition marker because its short half-life means that significant changes are seen within days or weeks.<sup><xref ref-type="bibr" rid="bibr84-0884533613486297">84</xref></sup> It has been claimed that this reflects nutrition input,<sup><xref ref-type="bibr" rid="bibr85-0884533613486297">85</xref></sup> but this has not been consistently supported in the literature. For example, serum prealbumin levels did not decrease when protein intake was decreased below the recommended minimum level in healthy volunteers,<sup><xref ref-type="bibr" rid="bibr86-0884533613486297">86</xref></sup> nor did they correlate with the extent of chronic weight loss in healthy volunteers<sup><xref ref-type="bibr" rid="bibr87-0884533613486297">87</xref></sup> or in patients with eating disorders.<sup><xref ref-type="bibr" rid="bibr88-0884533613486297">88</xref></sup> Studies suggesting that serum prealbumin level reflects nutrition rehabilitation are confounded by unrandomized design and the possible influence of inflammation.<sup><xref ref-type="bibr" rid="bibr89-0884533613486297">89</xref><xref ref-type="bibr" rid="bibr90-0884533613486297"/><xref ref-type="bibr" rid="bibr91-0884533613486297"/>-<xref ref-type="bibr" rid="bibr92-0884533613486297">92</xref></sup> A recent retrospective study in mostly critically ill patients found that serum prealbumin correated with inflammatory markers rather than with nutrition delivery.<sup><xref ref-type="bibr" rid="bibr93-0884533613486297">93</xref></sup> Concerns about this have been raised elsewhere<sup><xref ref-type="bibr" rid="bibr94-0884533613486297">94</xref>,<xref ref-type="bibr" rid="bibr95-0884533613486297">95</xref></sup> and are substantiated by the findings of this review of randomized studies, in which serum prealbumin did not consistently predict outcome and where even the supportive studies mostly reported clinically insignificant changes.</p>
<p>During a long ICU admission, patients often display marked catabolism, and this cannot be totally prevented by increasing nutrition support.<sup><xref ref-type="bibr" rid="bibr81-0884533613486297">81</xref>,<xref ref-type="bibr" rid="bibr96-0884533613486297">96</xref>,<xref ref-type="bibr" rid="bibr97-0884533613486297">97</xref></sup> The extent of catabolism may possibly be reduced with optimized nutrition, however. Currently, there is no validated way to measure nutrition response on a day-to-day basis, so it is not possible to feel confident that the current nutrition regimen is optimal or to assuage doubts about its adequacy when there is a poor clinical outcome later on. A short-term parameter that could reliably monitor response to nutrition in the critically ill, within the same timeframe as the nutrition therapy, would therefore be very valuable in clinical practice. Laboratory tests are particularly attractive in the intensive care setting as they are easily used in an unconscious patient, unlike many of the functional measures used outside the ICU such as grip strength. It may be the case that there will never be a “magic number” for assessing nutrition progress, and instead further work is needed to formalize the measurement of clinical outcomes such as ventilatory weaning, wound healing, and return of physical functioning, which are more meaningful to the individual patient.</p>
</sec>
<sec id="section17-0884533613486297" sec-type="conclusions">
<title>Conclusion</title>
<p>It appears that although outcomes in ICU can be improved in studies of various nutrition interventions, no commonly used anthropometric or biochemical indicator consistently predicts this. This suggests that assessing nutrition progress by monitoring such parameters, or aiming to achieve improvements in them by nutrition strategies, is not clinically meaningful.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0884533613486297">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>GL</given-names></name>
<name><surname>Bistrian</surname><given-names>B</given-names></name>
<name><surname>Roubenoff</surname><given-names>R</given-names></name>
<name><surname>Heimburger</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Malnutrition syndromes: a conundrum vs continuum</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>:<fpage>710</fpage>-<lpage>716</lpage>.</citation>
</ref>
<ref id="bibr2-0884533613486297">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>GL</given-names></name>
<name><surname>Mirtallo</surname><given-names>J</given-names></name>
<name><surname>Compher</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2010</year>;<volume>34</volume>:<fpage>156</fpage>-<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr3-0884533613486297">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Detsky</surname><given-names>AS</given-names></name>
<name><surname>Baker</surname><given-names>JP</given-names></name>
<name><surname>O’Rourke</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1987</year>;<volume>11</volume>:<fpage>440</fpage>-<lpage>446</lpage>.</citation>
</ref>
<ref id="bibr4-0884533613486297">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sungurtekin</surname><given-names>H</given-names></name>
<name><surname>Sungurtekin</surname><given-names>U</given-names></name>
<name><surname>Oner</surname><given-names>O</given-names></name>
<name><surname>Okke</surname><given-names>D</given-names></name>
</person-group>. <article-title>Nutrition assessment in critically ill patients</article-title>. <source>Nutr Clin Pract</source>. <year>2008</year>-<year>2009</year>;<volume>23</volume>(<issue>6</issue>):<fpage>635</fpage>-<lpage>641</lpage>.</citation>
</ref>
<ref id="bibr5-0884533613486297">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suarez-Santamaria</surname><given-names>M</given-names></name>
<name><surname>Santolaria</surname><given-names>F</given-names></name>
<name><surname>Perez-Ramirez</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis</article-title>. <source>Eur Cytokine Network</source>. <year>2010</year>;<volume>21</volume>(<issue>1</issue>):<fpage>19</fpage>-<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr6-0884533613486297">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheean</surname><given-names>PM</given-names></name>
<name><surname>Peterson</surname><given-names>SJ</given-names></name>
<name><surname>Gurka</surname><given-names>DP</given-names></name>
<name><surname>Braunschweig</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Nutrition assessment: the reproducibility of subjective global assessment in patients requiring mechanical ventilation</article-title>. <source>Eur J Clin Nutr</source>. <year>2010</year>;<volume>64</volume>(<issue>11</issue>):<fpage>1358</fpage>-<lpage>1364</lpage>.</citation>
</ref>
<ref id="bibr7-0884533613486297">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vincent</surname><given-names>JL</given-names></name>
<name><surname>Dubois</surname><given-names>MJ</given-names></name>
<name><surname>Nevickis</surname><given-names>RJ</given-names></name>
<name><surname>Wilkes</surname><given-names>MM</given-names></name>
</person-group>. <article-title>Hypoalbuminaemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials</article-title>. <source>Ann Surg</source>. <year>2003</year>;<volume>237</volume>(<issue>3</issue>):<fpage>319</fpage>-<lpage>334</lpage>.</citation>
</ref>
<ref id="bibr8-0884533613486297">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>NQ</given-names></name>
<name><surname>Fraser</surname><given-names>RJ</given-names></name>
<name><surname>Bryant</surname><given-names>LK</given-names></name><etal/>
</person-group>. <article-title>The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients</article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>5</issue>):<fpage>1655</fpage>-<lpage>1656</lpage>.</citation>
</ref>
<ref id="bibr9-0884533613486297">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alberda</surname><given-names>C</given-names></name>
<name><surname>Gramlich</surname><given-names>L</given-names></name>
<name><surname>Jones</surname><given-names>NE</given-names></name><etal/>
</person-group>. <article-title>The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observation study</article-title>. <source>Intensive Care Med</source>. <year>2009</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1728</fpage>-<lpage>1737</lpage>.</citation>
</ref>
<ref id="bibr10-0884533613486297">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heyland</surname><given-names>DK</given-names></name>
<name><surname>Dhaliwal</surname><given-names>R</given-names></name>
<name><surname>Drover</surname><given-names>JW</given-names></name>
<name><surname>Gramlich</surname><given-names>L</given-names></name>
<name><surname>Dodek</surname><given-names>P</given-names></name>
</person-group>. <article-title>Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2003</year>;<volume>27</volume>:<fpage>355</fpage>-<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr11-0884533613486297">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stapleton</surname><given-names>RD</given-names></name>
<name><surname>Jones</surname><given-names>N</given-names></name>
<name><surname>Heyland</surname><given-names>DK</given-names></name>
</person-group>. <article-title>Feeding critically ill patients: what is the optimal amount of energy?</article-title> <source>Crit Care Med</source>. <year>2007</year>;<volume>35</volume>:<fpage>S535</fpage>-<lpage>S540</lpage>.</citation>
</ref>
<ref id="bibr12-0884533613486297">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferrie</surname><given-names>S</given-names></name>
<name><surname>Allman-Farinelli</surname><given-names>M</given-names></name>
</person-group>. <article-title>Defining and evaluating the role of dietitians in intensive care: state of play</article-title>. <source>e-PEN J</source>. <year>2011</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e121</fpage>-<lpage>e125</lpage>.</citation>
</ref>
<ref id="bibr13-0884533613486297">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doig</surname><given-names>G</given-names></name>
<name><surname>Simpson</surname><given-names>F</given-names></name>
<name><surname>Delaney</surname><given-names>A</given-names></name>
</person-group>. <article-title>A review of the true methodological quality of nutritional support trials conducted in the critically ill: time for improvement</article-title>. <source>Anesth Analg</source>. <year>2005</year>;<volume>100</volume>:<fpage>527</fpage>-<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr14-0884533613486297">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graf</surname><given-names>J</given-names></name>
<name><surname>Doig</surname><given-names>GS</given-names></name>
<name><surname>Cook</surname><given-names>DJ</given-names></name><etal/>
</person-group>. <article-title>Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?</article-title> <source>Crit Care Med</source>. <year>2002</year>;<volume>30</volume>:<fpage>461</fpage>-<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr15-0884533613486297">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heyland</surname><given-names>DK</given-names></name>
<name><surname>MacDonald</surname><given-names>S</given-names></name>
<name><surname>Keefe</surname><given-names>L</given-names></name>
<name><surname>Drover</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Total parenteral nutrition in the critically ill patient: a meta-analysis</article-title>. <source>JAMA</source>. <year>1998</year>;<volume>280</volume>(<issue>23</issue>):<fpage>2013</fpage>-<lpage>2019</lpage>.</citation>
</ref>
<ref id="bibr16-0884533613486297">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauer</surname><given-names>P</given-names></name>
<name><surname>Charpentier</surname><given-names>C</given-names></name>
<name><surname>Bouchet</surname><given-names>C</given-names></name>
<name><surname>Nace</surname><given-names>L</given-names></name>
<name><surname>Raffy</surname><given-names>F</given-names></name>
<name><surname>Gaconnet</surname><given-names>N</given-names></name>
</person-group>. <article-title>Parenteral with enteral nutrition in the critically ill</article-title>. <source>Int Care Med</source>. <year>2000</year>;<volume>26</volume>:<fpage>893</fpage>-<lpage>900</lpage>.</citation>
</ref>
<ref id="bibr17-0884533613486297">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fuentes-Orozco</surname><given-names>C</given-names></name>
<name><surname>Cervantes-Guevara</surname><given-names>G</given-names></name>
<name><surname>Muciño-Hernández</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>L-alanyl-L-glutamine–supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2008</year>;<volume>32</volume>(<issue>4</issue>):<fpage>403</fpage>-<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr18-0884533613486297">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garcia-de-Lorenzo</surname><given-names>A</given-names></name>
<name><surname>Ortiz-Leyba</surname><given-names>C</given-names></name>
<name><surname>Planas</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects</article-title>. <source>Crit Care Med</source>. <year>1997</year>;<volume>25</volume>(<issue>3</issue>):<fpage>418</fpage>-<lpage>424</lpage>.</citation>
</ref>
<ref id="bibr19-0884533613486297">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname><given-names>X-L</given-names></name>
<name><surname>Ma</surname><given-names>Q-J</given-names></name>
<name><surname>Lu</surname><given-names>J-G</given-names></name>
<name><surname>Chu</surname><given-names>Y-K</given-names></name>
<name><surname>Du</surname><given-names>X-L</given-names></name>
</person-group>. <article-title>Effect of total parenteral nutrition (TPN) with and without glutamine dipeptide supplementation on outcome in severe acute pancreatitis (SAP)</article-title>. <source>Clin Nutr Suppl</source>. <year>2004</year>;<volume>1</volume>(<issue>1</issue>):<fpage>43</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr20-0884533613486297">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iovinelli</surname><given-names>G</given-names></name>
<name><surname>Marinangeli</surname><given-names>F</given-names></name>
<name><surname>Ciccone</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Parenteral nutrition in ventilated patients with chronic obstructive pulmonary disease: long chain vs medium chain triglycerides</article-title>. <source>Minerva Anestesiol</source>. <year>2007</year>;<volume>73</volume>(<issue>1-2</issue>):<fpage>65</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr21-0884533613486297">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaur</surname><given-names>N</given-names></name>
<name><surname>Gupta</surname><given-names>MK</given-names></name>
<name><surname>Minocha</surname><given-names>VR</given-names></name>
</person-group>. <article-title>Early enteral feeding by nasoenteric tubes in patients with perforation peritonitis</article-title>. <source>World J Surg</source>. <year>2005</year>;<volume>29</volume>(<issue>8</issue>):<fpage>1023</fpage>-<lpage>1027</lpage>.</citation>
</ref>
<ref id="bibr22-0884533613486297">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Q</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Chen</surname><given-names>H</given-names></name>
<name><surname>Ma</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Treatment with growth hormone, somatostatin, and insulin in combination with hypocaloric parenteral nutrition in gastrointestinal cancer patients after surgery</article-title>. <source>Nutrition</source>. <year>2011</year>;<volume>27</volume>(<issue>6</issue>):<fpage>633</fpage>-<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr23-0884533613486297">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>CY</given-names></name>
<name><surname>Shih</surname><given-names>YL</given-names></name>
<name><surname>Sun</surname><given-names>LC</given-names></name><etal/>
</person-group>. <article-title>The inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patients</article-title>. <source>Am Surg</source>. <year>2011</year>;<volume>77</volume>(<issue>1</issue>):<fpage>59</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr24-0884533613486297">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>G</given-names></name>
<name><surname>Ram</surname><given-names>RP</given-names></name>
<name><surname>Khanna</surname><given-names>SK</given-names></name>
</person-group>. <article-title>Early postoperative enteral feeding in patients with nontraumatic intestinal perforation and peritonitis</article-title>. <source>J Am Coll Surg</source>. <year>1998</year>;<volume>187</volume>(<issue>2</issue>):<fpage>142</fpage>-<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr25-0884533613486297">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tiengou</surname><given-names>LE</given-names></name>
<name><surname>Gloro</surname><given-names>R</given-names></name>
<name><surname>Pouzoulet</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2006</year>;<volume>30</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr26-0884533613486297">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wischmeyer</surname><given-names>PE</given-names></name>
<name><surname>Lynch</surname><given-names>J</given-names></name>
<name><surname>Liedel</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control</article-title>. <source>Crit Care Med</source>. <year>2001</year>;<volume>29</volume>(<issue>11</issue>):<fpage>2075</fpage>-<lpage>2080</lpage>.</citation>
</ref>
<ref id="bibr27-0884533613486297">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Zhong</surname><given-names>Y</given-names></name>
<name><surname>Jing</surname><given-names>D</given-names></name>
<name><surname>Wu</surname><given-names>Z</given-names></name>
</person-group>. <article-title>Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer</article-title>. <source>World J Surg</source>. <year>2006</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1284</fpage>-<lpage>1289</lpage>.</citation>
</ref>
<ref id="bibr28-0884533613486297">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Battistella</surname><given-names>FD</given-names></name>
<name><surname>Widergren</surname><given-names>JT</given-names></name>
<name><surname>Anderson</surname><given-names>JT</given-names></name>
<name><surname>Siepler</surname><given-names>JK</given-names></name>
<name><surname>Weber</surname><given-names>JC</given-names></name>
<name><surname>MacColl</surname><given-names>K</given-names></name>
</person-group>. <article-title>A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition</article-title>. <source>J Trauma</source>. <year>1997</year>;<volume>43</volume>(<issue>1</issue>):<fpage>52</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr29-0884533613486297">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beier-Holgersen</surname><given-names>R</given-names></name>
<name><surname>Brandstrup</surname><given-names>B</given-names></name>
</person-group>. <article-title>Influence of early postoperative enteral nutrition versus placebo on cell-mediated immunity, as measured with the Multitest CMI</article-title>. <source>Scand J Gastroenterol</source>. <year>1999</year>;<volume>34</volume>(<issue>1</issue>):<fpage>98</fpage>-<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr30-0884533613486297">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Déchelotte</surname><given-names>P</given-names></name>
<name><surname>Hasselmann</surname><given-names>M</given-names></name>
<name><surname>Cynober</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study</article-title>. <source>Crit Care Med</source>. <year>2006</year>;<volume>34</volume>(<issue>3</issue>):<fpage>598</fpage>-<lpage>604</lpage>.</citation>
</ref>
<ref id="bibr31-0884533613486297">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Falcão</surname><given-names>de</given-names></name>
<name><surname>Arruda</surname><given-names>IS</given-names></name>
<name><surname>de Aguilar-Nascimento</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients</article-title>. <source>Clin Sci</source>. <year>2004</year>;<volume>106</volume>(<issue>3</issue>):<fpage>287</fpage>-<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr32-0884533613486297">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goeters</surname><given-names>C</given-names></name>
<name><surname>Wenn</surname><given-names>A</given-names></name>
<name><surname>Mertes</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients</article-title>. <source>Crit Care Med</source>. <year>2002</year>;<volume>30</volume>(<issue>9</issue>):<fpage>2032</fpage>-<lpage>2037</lpage>.</citation>
</ref>
<ref id="bibr33-0884533613486297">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Luis</surname><given-names>DA</given-names></name>
<name><surname>Izaola</surname><given-names>O</given-names></name>
<name><surname>Cuellar</surname><given-names>L</given-names></name>
<name><surname>Terroba</surname><given-names>MC</given-names></name>
<name><surname>Aller</surname><given-names>R</given-names></name>
</person-group>. <article-title>Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients</article-title>. <source>Eur J Clin Nutr</source>. <year>2004</year>;<volume>58</volume>(<issue>11</issue>):<fpage>1505</fpage>-<lpage>1508</lpage>.</citation>
</ref>
<ref id="bibr34-0884533613486297">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Luis</surname><given-names>DA</given-names></name>
<name><surname>Izaola</surname><given-names>O</given-names></name>
<name><surname>Cuellar</surname><given-names>L</given-names></name>
<name><surname>Terroba</surname><given-names>MC</given-names></name>
<name><surname>Martin</surname><given-names>T</given-names></name>
<name><surname>Aller</surname><given-names>R</given-names></name>
</person-group>. <article-title>Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patients</article-title>. <source>Eur J Clin Nutr</source>. <year>2007</year>;<volume>61</volume>(<issue>2</issue>):<fpage>200</fpage>-<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr35-0884533613486297">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Luis</surname><given-names>DA</given-names></name>
<name><surname>Izaola</surname><given-names>O</given-names></name>
<name><surname>Cuellar</surname><given-names>L</given-names></name>
<name><surname>Terroba</surname><given-names>MC</given-names></name>
<name><surname>Martin</surname><given-names>T</given-names></name>
<name><surname>Aller</surname><given-names>R</given-names></name>
</person-group>. <article-title>High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients: a randomized clinical trial</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2009</year>;<volume>13</volume>(<issue>4</issue>):<fpage>279</fpage>-<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr36-0884533613486297">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Theilla</surname><given-names>M</given-names></name>
<name><surname>Singer</surname><given-names>P</given-names></name>
<name><surname>Cohen</surname><given-names>J</given-names></name>
<name><surname>Dekeyser</surname><given-names>F</given-names></name>
</person-group>. <article-title>A diet enriched in eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study</article-title>. <source>Clin Nutr</source>. <year>2007</year>;<volume>26</volume>(<issue>6</issue>):<fpage>752</fpage>-<lpage>757</lpage>.</citation>
</ref>
<ref id="bibr37-0884533613486297">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barbosa</surname><given-names>VM</given-names></name>
<name><surname>Miles</surname><given-names>EA</given-names></name>
<name><surname>Calhau</surname><given-names>C</given-names></name>
<name><surname>Lafuente</surname><given-names>E</given-names></name>
<name><surname>Calder</surname><given-names>PC</given-names></name>
</person-group>. <article-title>Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial</article-title>. <source>Crit Care</source>. <year>2010</year>;<volume>14</volume>(<issue>1</issue>):<fpage>R5</fpage>.</citation>
</ref>
<ref id="bibr38-0884533613486297">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boivin</surname><given-names>MA</given-names></name>
<name><surname>Levy</surname><given-names>H</given-names></name>
</person-group>. <article-title>Gastric feeding with erythromycin is equivalent to transpyloric feeding in the critically ill</article-title>. <source>Crit Care Med</source>. <year>2001</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1916</fpage>-<lpage>1919</lpage>.</citation>
</ref>
<ref id="bibr39-0884533613486297">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Braga</surname><given-names>M</given-names></name>
<name><surname>Gianotti</surname><given-names>L</given-names></name>
<name><surname>Gentilini</surname><given-names>O</given-names></name>
<name><surname>Parisi</surname><given-names>V</given-names></name>
<name><surname>Salis</surname><given-names>C</given-names></name>
<name><surname>Di Carlo</surname><given-names>V</given-names></name>
</person-group>. <article-title>Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition</article-title>. <source>Crit Care Med</source>. <year>2001</year>;<volume>29</volume>(<issue>2</issue>):<fpage>242</fpage>-<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr40-0884533613486297">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carr</surname><given-names>CS</given-names></name>
<name><surname>Ling</surname><given-names>KDE</given-names></name>
<name><surname>Boulos</surname><given-names>P</given-names></name>
<name><surname>Singer</surname><given-names>M</given-names></name>
</person-group>. <article-title>Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection</article-title>. <source>Br Med J</source>. <year>1996</year>;<volume>312</volume>(<issue>7035</issue>):<fpage>869</fpage>-<lpage>871</lpage>.</citation>
</ref>
<ref id="bibr41-0884533613486297">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Casas Rodera</surname><given-names>P</given-names></name>
<name><surname>Gómez-Candela</surname><given-names>C</given-names></name>
<name><surname>Benitez</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial</article-title>. <source>Nutr Hosp</source>. <year>2008</year>;<volume>23</volume>(<issue>2</issue>):<fpage>105</fpage>-<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr42-0884533613486297">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cekmen</surname><given-names>N</given-names></name>
<name><surname>Aydimathn</surname><given-names>A</given-names></name>
<name><surname>Erdemli</surname><given-names>O</given-names></name>
</person-group>. <article-title>The impact of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on clinical outcome in critically patients</article-title>. <source>e-SPEN J</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e64</fpage>-<lpage>e67</lpage>.</citation>
</ref>
<ref id="bibr43-0884533613486297">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>FM</given-names></name>
<name><surname>Wang</surname><given-names>JY</given-names></name>
<name><surname>Sun</surname><given-names>LC</given-names></name>
<name><surname>Juang</surname><given-names>RF</given-names></name>
<name><surname>Huang</surname><given-names>TJ</given-names></name>
<name><surname>Hsieh</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Efficacy of medium-chain triglycerides compared with long-chain triglycerides in total parenteral nutrition in patients with digestive tract cancer undergoing surgery</article-title>. <source>Kaohsiung J Med Sci</source>. <year>2005</year>;<volume>21</volume>(<issue>11</issue>):<fpage>487</fpage>-<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr44-0884533613486297">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Day</surname><given-names>L</given-names></name>
<name><surname>Stotts</surname><given-names>NA</given-names></name>
<name><surname>Frankfurt</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Gastric versus duodenal feeding in patients with neurological disease: a pilot study</article-title>. <source>J Neurosci Nurs</source>. <year>2001</year>;<volume>33</volume>(<issue>3</issue>):<fpage>148</fpage>-<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr45-0884533613486297">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dhanraj</surname><given-names>P</given-names></name>
<name><surname>Chacko</surname><given-names>A</given-names></name>
<name><surname>Mammen</surname><given-names>M</given-names></name>
<name><surname>Bharathi</surname><given-names>R</given-names></name>
</person-group>. <article-title>Hospital-made diet versus commercial supplement in postburn nutritional support</article-title>. <source>Burns</source>. <year>1997</year>;<volume>23</volume>(<issue>6</issue>):<fpage>512</fpage>-<lpage>514</lpage>.</citation>
</ref>
<ref id="bibr46-0884533613486297">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dvorak</surname><given-names>MF</given-names></name>
<name><surname>Noonan</surname><given-names>VK</given-names></name>
<name><surname>Belanger</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Early versus late enteral feeding in patients with acute cervical spinal cord injury: a pilot study</article-title>. <source>Spine</source>. <year>2004</year>;<volume>29</volume>(<issue>9</issue>):<fpage>E175</fpage>-<lpage>E180</lpage>.</citation>
</ref>
<ref id="bibr47-0884533613486297">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garcia-de-Lorenzo</surname><given-names>A</given-names></name>
<name><surname>Denia</surname><given-names>R</given-names></name>
<name><surname>Atlan</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil–based lipid emulsion v. medium/long-chain triacylglycerols</article-title>. <source>Br J Nutr</source>. <year>2005</year>;<volume>94</volume>(<issue>2</issue>):<fpage>221</fpage>-<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr48-0884533613486297">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garnacho-Montero</surname><given-names>J</given-names></name>
<name><surname>Ortiz-Leyba</surname><given-names>C</given-names></name>
<name><surname>Jiménez-Jiménez</surname><given-names>FJ</given-names></name><etal/>
</person-group>. <article-title>Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients</article-title>. <source>Nutrition</source>. <year>2002</year>;<volume>18</volume>(<issue>2</issue>):<fpage>134</fpage>-<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr49-0884533613486297">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gervasio</surname><given-names>JM</given-names></name>
<name><surname>Dickerson</surname><given-names>RN</given-names></name>
<name><surname>Swearingen</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Oxandrolone in trauma patients</article-title>. <source>Pharmacotherapy</source>. <year>2000</year>;<volume>20</volume>(<issue>11</issue>):<fpage>1328</fpage>-<lpage>1334</lpage>.</citation>
</ref>
<ref id="bibr50-0884533613486297">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hallay</surname><given-names>J</given-names></name>
<name><surname>Kovacs</surname><given-names>G</given-names></name>
<name><surname>Kiss Sz</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Changes in the nutritional state and immune-serological parameters of esophagectomized patients fed jejunely with glutamine-poor and glutamine-rich nutriments</article-title>. <source>Hepatogastroenterology</source>. <year>2002</year>;<volume>49</volume>(<issue>48</issue>):<fpage>1555</fpage>-<lpage>1559</lpage>.</citation>
</ref>
<ref id="bibr51-0884533613486297">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hatton</surname><given-names>J</given-names></name>
<name><surname>Kryscio</surname><given-names>R</given-names></name>
<name><surname>Ryan</surname><given-names>M</given-names></name>
<name><surname>Linda</surname><given-names>O</given-names></name>
<name><surname>Young</surname><given-names>B</given-names></name>
</person-group>. <article-title>Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury</article-title>. <source>J Neurosurg</source>. <year>2006</year>;<volume>105</volume>(<issue>6</issue>):<fpage>843</fpage>-<lpage>852</lpage>.</citation>
</ref>
<ref id="bibr52-0884533613486297">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jones</surname><given-names>C</given-names></name>
<name><surname>Palmer</surname><given-names>TEA</given-names></name>
<name><surname>Griffiths</surname><given-names>RD</given-names></name>
</person-group>. <article-title>Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition</article-title>. <source>Nutrition</source>. <year>1999</year>;<volume>15</volume>(<issue>2</issue>):<fpage>108</fpage>-<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr53-0884533613486297">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Justo Meirelles</surname><given-names>CM</given-names></name>
<name><surname>de Aguilar-Nascimento</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Enteral or parenteral nutrition in traumatic brain injury: a prospective randomised trial</article-title>. <source>Nutr Hosp</source>. <year>2011</year>;<volume>26</volume>(<issue>5</issue>):<fpage>1120</fpage>-<lpage>1124</lpage>.</citation>
</ref>
<ref id="bibr54-0884533613486297">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kearns</surname><given-names>PJ</given-names></name>
<name><surname>Chin</surname><given-names>D</given-names></name>
<name><surname>Mueller</surname><given-names>L</given-names></name>
<name><surname>Wallace</surname><given-names>K</given-names></name>
<name><surname>Jensen</surname><given-names>WA</given-names></name>
<name><surname>Kirsch</surname><given-names>CM</given-names></name>
</person-group>. <article-title>The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: a randomized clinical trial</article-title>. <source>Crit Care Med</source>. <year>2000</year>;<volume>28</volume>(<issue>6</issue>):<fpage>1742</fpage>-<lpage>1746</lpage>.</citation>
</ref>
<ref id="bibr55-0884533613486297">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Ledinghen</surname><given-names>V</given-names></name>
<name><surname>Beau</surname><given-names>P</given-names></name>
<name><surname>Mannant</surname><given-names>PR</given-names></name><etal/>
</person-group>. <article-title>Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study</article-title>. <source>Dig Dis Sci</source>. <year>1997</year>;<volume>42</volume>(<issue>3</issue>):<fpage>536</fpage>-<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr56-0884533613486297">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lo</surname><given-names>HC</given-names></name>
<name><surname>Lin</surname><given-names>CH</given-names></name>
<name><surname>Tsai</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>Effects of hypercaloric feeding on nutrition status and carbon dioxide production in patients with long-term mechanical ventilation</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2005</year>;<volume>29</volume>(<issue>5</issue>):<fpage>380</fpage>-<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr57-0884533613486297">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montecalvo</surname><given-names>MA</given-names></name>
<name><surname>Steger</surname><given-names>KA</given-names></name>
<name><surname>Farber</surname><given-names>HW</given-names></name><etal/>
</person-group>. <article-title>Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings</article-title>. <source>Crit Care Med</source>. <year>1992</year>;<volume>20</volume>(<issue>10</issue>):<fpage>1377</fpage>-<lpage>1387</lpage>.</citation>
</ref>
<ref id="bibr58-0884533613486297">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>Y</given-names></name>
<name><surname>Zhu</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Xu</surname><given-names>Q</given-names></name>
<name><surname>Ding</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Nutrition support with glutamine dipeptide in patients undergoing liver transplantation</article-title>. <source>Transplant Proc</source>. <year>2009</year>;<volume>41</volume>(<issue>10</issue>):<fpage>4232</fpage>-<lpage>4237</lpage>.</citation>
</ref>
<ref id="bibr59-0884533613486297">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riso</surname><given-names>S</given-names></name>
<name><surname>Aluffi</surname><given-names>P</given-names></name>
<name><surname>Brugnani</surname><given-names>M</given-names></name>
<name><surname>Farinetti</surname><given-names>F</given-names></name>
<name><surname>Pia</surname><given-names>F</given-names></name>
<name><surname>d’Andrea</surname><given-names>F</given-names></name>
</person-group>. <article-title>Postoperative enteral immunonutrition in head and neck cancer patients</article-title>. <source>Clin Nutr</source>. <year>2000</year>;<volume>19</volume>(<issue>6</issue>):<fpage>407</fpage>-<lpage>412</lpage>.</citation>
</ref>
<ref id="bibr60-0884533613486297">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watters</surname><given-names>JM</given-names></name>
<name><surname>Kirkpatrick</surname><given-names>SM</given-names></name>
<name><surname>Norris</surname><given-names>SB</given-names></name>
<name><surname>Shamji</surname><given-names>FM</given-names></name>
<name><surname>Wells</surname><given-names>GA</given-names></name>
</person-group>. <article-title>Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility</article-title>. <source>Ann Surg</source>. <year>1997</year>;<volume>226</volume>(<issue>3</issue>):<fpage>369</fpage>-<lpage>377</lpage>, discussion 377-380.</citation>
</ref>
<ref id="bibr61-0884533613486297">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wicks</surname><given-names>C</given-names></name>
<name><surname>Somasundaram</surname><given-names>S</given-names></name>
<name><surname>Bjarnason</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>Comparison of enteral feeding and total parenteral nutrition after liver transplantation</article-title>. <source>Lancet</source>. <year>1994</year>;<volume>344</volume>(<issue>8926</issue>):<fpage>837</fpage>-<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr62-0884533613486297">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wiren</surname><given-names>M</given-names></name>
<name><surname>Permert</surname><given-names>J</given-names></name>
<name><surname>Larsson</surname><given-names>J</given-names></name>
</person-group>. <article-title>Alpha-ketoglutarate–supplemented enteral nutrition: effects on postoperative nitrogen balance and muscle catabolism</article-title>. <source>Nutrition</source>. <year>2002</year>;<volume>18</volume>(<issue>9</issue>):<fpage>725</fpage>-<lpage>728</lpage>.</citation>
</ref>
<ref id="bibr63-0884533613486297">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>CW</given-names></name>
<name><surname>Meng</surname><given-names>HC</given-names></name>
<name><surname>Mok</surname><given-names>KT</given-names></name><etal/>
</person-group>. <article-title>Effect of total parenteral nutrition on the postoperative outcome in aged patients with gastric cancer</article-title>. <source>Dig Surg</source>. <year>1995</year>;<volume>12</volume>(<issue>3</issue>):<fpage>164</fpage>-<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr64-0884533613486297">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yeh</surname><given-names>CN</given-names></name>
<name><surname>Lee</surname><given-names>HL</given-names></name>
<name><surname>Liu</surname><given-names>YY</given-names></name><etal/>
</person-group>. <article-title>The role of parenteral glutamine supplement for surgical patient perioperatively: result of a single center, prospective and controlled study</article-title>. <source>Langenbecks Arch Surg</source>. <year>2008</year>;<volume>393</volume>(<issue>6</issue>):<fpage>849</fpage>-<lpage>855</lpage>.</citation>
</ref>
<ref id="bibr65-0884533613486297">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>MM</given-names></name>
<name><surname>Wu</surname><given-names>XT</given-names></name>
<name><surname>Zhou</surname><given-names>Y</given-names></name>
<name><surname>Qian</surname><given-names>K</given-names></name>
<name><surname>Zheng</surname><given-names>YM</given-names></name>
</person-group>. <article-title>Short-term application of low-dose growth hormone in surgical patients: effects on nitrogen balance and blood glucose</article-title>. <source>World J Gastroenterol</source>. <year>2007</year>;<volume>13</volume>(<issue>3</issue>):<fpage>452</fpage>-<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr66-0884533613486297">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>W</given-names></name>
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Zhao</surname><given-names>Z</given-names></name><etal/>
</person-group>. <article-title>The effect of early enteral nutritive support on patients after esophageal and gastric operation</article-title>. <source>Chin J Clin Rehabil</source>. <year>2003</year>;<volume>7</volume>(<issue>1</issue>):<fpage>146</fpage>-<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr67-0884533613486297">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>YC</given-names></name>
<name><surname>Yen</surname><given-names>CE</given-names></name>
<name><surname>Cheng</surname><given-names>CH</given-names></name><etal/>
</person-group>. <article-title>Nutritional status of mechanically ventilated critically ill patients: comparison of different types of nutritional support</article-title>. <source>Clin Nutr</source>. <year>2000</year>;<volume>19</volume>:<fpage>101</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr68-0884533613486297">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nataloni</surname><given-names>S</given-names></name>
<name><surname>Gentili</surname><given-names>P</given-names></name>
<name><surname>Marini</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Nutritional assessment in head injured patients through the study of rapid turnover visceral proteins</article-title>. <source>Clin Nutr</source>. <year>1999</year>;<volume>18</volume>(<issue>4</issue>):<fpage>247</fpage>-<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr69-0884533613486297">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Phang</surname><given-names>PT</given-names></name>
<name><surname>Aeberhardt</surname><given-names>LE</given-names></name>
</person-group>. <article-title>Effect of nutritional support on routine nutrition assessment parameters and body composition in intensive care unit patients</article-title>. <source>Can J Surg</source>. <year>1996</year>;<volume>39</volume>(<issue>3</issue>):<fpage>212</fpage>-<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr70-0884533613486297">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carpentier</surname><given-names>YA</given-names></name>
<name><surname>Barthel</surname><given-names>J</given-names></name>
<name><surname>Bruyns</surname><given-names>J</given-names></name>
</person-group>. <article-title>Plasma protein concentration in nutritional assessment</article-title>. <source>Proc Nutr Soc</source>. <year>1982</year>;<volume>41</volume>:<fpage>405</fpage>-<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr71-0884533613486297">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vincent</surname><given-names>JL</given-names></name>
<name><surname>Dubois</surname><given-names>MJ</given-names></name>
<name><surname>Nevickis</surname><given-names>RJ</given-names></name>
<name><surname>Wilkes</surname><given-names>MM</given-names></name>
</person-group>. <article-title>Hypoalbuminaemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials</article-title>. <source>Ann Surg</source>. <year>2003</year>;<volume>237</volume>(<issue>3</issue>):<fpage>319</fpage>-<lpage>334</lpage>.</citation>
</ref>
<ref id="bibr72-0884533613486297">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franch-Arcas</surname><given-names>G</given-names></name>
</person-group>. <article-title>The meaning of hypoalbuminaemia in clinical practice</article-title>. <source>Clin Nutr</source>. <year>2001</year>;<volume>20</volume>(<issue>3</issue>):<fpage>265</fpage>-<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr73-0884533613486297">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>GE</given-names></name>
<name><surname>Meguid</surname><given-names>MM</given-names></name>
</person-group>. <article-title>Can total parenteral nutrition reverse hypoalbuminaemia in oncology patients?</article-title> <source>Nutrition</source>. <year>1990</year>;<volume>6</volume>:<fpage>225</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr74-0884533613486297">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bistrian</surname><given-names>BR</given-names></name>
<name><surname>Blackburn</surname><given-names>GL</given-names></name>
<name><surname>Scrimshaw</surname><given-names>NS</given-names></name><etal/>
</person-group>. <article-title>Cellular immunity in semi-starved states in hospitalized adults</article-title>. <source>Am J Clin Nutr</source>. <year>1975</year>;<volume>28</volume>:<fpage>1148</fpage>-<lpage>1155</lpage>.</citation>
</ref>
<ref id="bibr75-0884533613486297">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seltzer</surname><given-names>MH</given-names></name>
<name><surname>Bastidas</surname><given-names>JA</given-names></name>
<name><surname>Cooper</surname><given-names>DM</given-names></name><etal/>
</person-group>. <article-title>Instant nutritional assessment</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1979</year>;<volume>3</volume>:<fpage>157</fpage>-<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr76-0884533613486297">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brugler</surname><given-names>L</given-names></name>
<name><surname>Stankovic</surname><given-names>AK</given-names></name>
<name><surname>Schlefer</surname><given-names>M</given-names></name>
<name><surname>Bernstein</surname><given-names>L</given-names></name>
</person-group>. <article-title>A simplified nutrition screen for hospitalized patients using readily available laboratory and patient information</article-title>. <source>Nutrition</source>. <year>2005</year>;<volume>21</volume>:<fpage>650</fpage>-<lpage>658</lpage>.</citation>
</ref>
<ref id="bibr77-0884533613486297">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Laporte</surname><given-names>M</given-names></name>
<name><surname>Villalon</surname><given-names>L</given-names></name>
<name><surname>Payette</surname><given-names>H</given-names></name>
</person-group>. <article-title>Simple nutrition screening tools for health care facilities: development and validity assessment</article-title>. <source>Can J Diet Prac Res</source>. <year>2001</year>;<volume>62</volume>:<fpage>26</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr78-0884533613486297">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Azad</surname><given-names>N</given-names></name>
<name><surname>Murphy</surname><given-names>J</given-names></name>
<name><surname>Amos</surname><given-names>SS</given-names></name><etal/>
</person-group>. <article-title>Nutrition survey in an elderly population following admission to a tertiary care hospital</article-title>. <source>CMAJ</source>. <year>1999</year>;<volume>161</volume>:<fpage>511</fpage>-<lpage>515</lpage>.</citation>
</ref>
<ref id="bibr79-0884533613486297">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guimaraes</surname><given-names>SM</given-names></name>
<name><surname>Lima</surname><given-names>EQ</given-names></name>
<name><surname>Cipullo</surname><given-names>JP</given-names></name>
<name><surname>Lobo</surname><given-names>SM</given-names></name>
<name><surname>Burdmann</surname><given-names>EA</given-names></name>
</person-group>. <article-title>Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit</article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>12</issue>):<fpage>3165</fpage>-<lpage>3170</lpage>.</citation>
</ref>
<ref id="bibr80-0884533613486297">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravasco</surname><given-names>P</given-names></name>
<name><surname>Camilo</surname><given-names>ME</given-names></name>
<name><surname>Gouveia-Oliveira</surname><given-names>A</given-names></name>
<name><surname>Adam</surname><given-names>S</given-names></name>
<name><surname>Brum</surname><given-names>G</given-names></name>
</person-group>. <article-title>A critical approach to nutritional assessment in critically ill patients</article-title>. <source>Clin Nutr</source>. <year>2002</year>;<volume>21</volume>(<issue>1</issue>):<fpage>73</fpage>-<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr81-0884533613486297">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Monk</surname><given-names>DN</given-names></name>
<name><surname>Plank</surname><given-names>LD</given-names></name>
<name><surname>Franch-Arcas</surname><given-names>G</given-names></name>
<name><surname>Finn</surname><given-names>PJ</given-names></name>
<name><surname>Streat</surname><given-names>SJ</given-names></name>
<name><surname>Hill</surname><given-names>GL</given-names></name>
</person-group>. <article-title>Sequential changes in the metabolic response in critically injured patients during the first 25 days after blunt trauma</article-title>. <source>Ann Surg</source>. <year>1996</year>;<volume>223</volume>(<issue>4</issue>):<fpage>395</fpage>-<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr82-0884533613486297">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hill</surname><given-names>AA</given-names></name>
<name><surname>Plank</surname><given-names>LD</given-names></name>
<name><surname>Finn</surname><given-names>PJ</given-names></name><etal/>
</person-group>. <article-title>Massive nitrogen loss in critical surgical illness: effect on cardiac mass and function</article-title>. <source>Ann Surg</source>. <year>1997</year>;<volume>226</volume>(<issue>2</issue>):<fpage>191</fpage>-<lpage>197</lpage>.</citation>
</ref>
<ref id="bibr83-0884533613486297">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Finn</surname><given-names>PJ</given-names></name>
<name><surname>Plank</surname><given-names>LD</given-names></name>
<name><surname>Clark</surname><given-names>MA</given-names></name>
<name><surname>Connolly</surname><given-names>AB</given-names></name>
<name><surname>Hill</surname><given-names>GL</given-names></name>
</person-group>. <article-title>Assessment of involuntary muscle function in patients after critical injury or severe sepsis</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1996</year>;<volume>20</volume>(<issue>5</issue>):<fpage>332</fpage>-<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr84-0884533613486297">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raguso</surname><given-names>CA</given-names></name>
<name><surname>Dupertuis</surname><given-names>YM</given-names></name>
<name><surname>Pichard</surname><given-names>C</given-names></name>
</person-group>. <article-title>The role of visceral proteins in the nutritional assessment of intensive care unit patients</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2003</year>;<volume>6</volume>:<fpage>211</fpage>-<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr85-0884533613486297">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ingenbleek</surname><given-names>Y</given-names></name>
<name><surname>Young</surname><given-names>VR</given-names></name>
</person-group>. <article-title>Significance of transthyretin in protein metabolism</article-title>. <source>Clin Chem Lab Med</source>. <year>2002</year>;<volume>40</volume>(<issue>12</issue>):<fpage>1281</fpage>-<lpage>1291</lpage>.</citation>
</ref>
<ref id="bibr86-0884533613486297">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>AA</given-names></name>
<name><surname>Phillips</surname><given-names>G</given-names></name>
<name><surname>McClelland</surname><given-names>I</given-names></name>
<name><surname>Jahoor</surname><given-names>F</given-names></name>
</person-group>. <article-title>Synthesis of hepatic secretory proteins in normal adults consuming a diet marginally adequate in protein</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2001</year>;<volume>281</volume>:<fpage>G1179</fpage>-<lpage>G1187</lpage>.</citation>
</ref>
<ref id="bibr87-0884533613486297">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Afolabi</surname><given-names>PR</given-names></name>
<name><surname>Jahoor</surname><given-names>F</given-names></name>
<name><surname>Jackson</surname><given-names>AA</given-names></name><etal/>
</person-group>. <article-title>The effect of total starvation and very low energy diet in lean men on kinetics of whole body protein and five hepatic secretory proteins</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2007</year>;<volume>293</volume>(<issue>6</issue>):<fpage>E1580</fpage>-<lpage>E1589</lpage>.</citation>
</ref>
<ref id="bibr88-0884533613486297">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nova</surname><given-names>E</given-names></name>
<name><surname>Lopez-Vidriero</surname><given-names>I</given-names></name>
<name><surname>Varela</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Indicators of nutritional status in restricting-type anorexia nervosa patients: a 1-year follow-up study</article-title>. <source>Clin Nutr</source>. <year>2004</year>;<volume>23</volume>:<fpage>1353</fpage>-<lpage>1359</lpage>.</citation>
</ref>
<ref id="bibr89-0884533613486297">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morlese</surname><given-names>JF</given-names></name>
<name><surname>Forrester</surname><given-names>T</given-names></name>
<name><surname>Del Rosario</surname><given-names>M</given-names></name>
<name><surname>Frazer</surname><given-names>M</given-names></name>
<name><surname>Jahoor</surname><given-names>F</given-names></name>
</person-group>. <article-title>Depletion of the plasma pool of nutrient transport proteins occurs at different rates during the nutritional rehabilitation of severely malnourished children</article-title>. <source>J Nutr</source>. <year>1998</year>;<volume>128</volume>:<fpage>214</fpage>-<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr90-0884533613486297">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Casati</surname><given-names>A</given-names></name>
<name><surname>Muttini</surname><given-names>S</given-names></name>
<name><surname>Leggieri</surname><given-names>C</given-names></name>
<name><surname>Colombo</surname><given-names>S</given-names></name>
<name><surname>Giorgi</surname><given-names>E</given-names></name>
<name><surname>Torri</surname><given-names>G</given-names></name>
</person-group>. <article-title>Rapid turnover proteins in critically ill patients: negative acute phase proteins or nutritional indicators?</article-title> <source>Minerva Anestesiol</source>. <year>1998</year>;<volume>64</volume>(<issue>7-8</issue>):<fpage>345</fpage>-<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr91-0884533613486297">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boles</surname><given-names>JM</given-names></name>
<name><surname>Garre</surname><given-names>MA</given-names></name>
<name><surname>Youinou</surname><given-names>PY</given-names></name><etal/>
</person-group>. <article-title>Nutritional status in intensive care patients: evaluation in 84 unselected patients</article-title>. <source>Crit Care Med</source>. <year>1983</year>;<volume>11</volume>(<issue>2</issue>):<fpage>87</fpage>-<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr92-0884533613486297">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hawker</surname><given-names>FH</given-names></name>
<name><surname>Stewart</surname><given-names>PM</given-names></name>
<name><surname>Baxter</surname><given-names>RC</given-names></name><etal/>
</person-group>. <article-title>Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients</article-title>. <source>Crit Care Med</source>. <year>1987</year>;<volume>15</volume>(<issue>8</issue>):<fpage>732</fpage>-<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr93-0884533613486297">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>CJ</given-names></name>
<name><surname>Sowa</surname><given-names>D</given-names></name>
<name><surname>Keim</surname><given-names>KS</given-names></name>
<name><surname>Kinnare</surname><given-names>K</given-names></name>
<name><surname>Peterson</surname><given-names>S</given-names></name>
</person-group>. <article-title>The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>(<issue>2</issue>):<fpage>197</fpage>-<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr94-0884533613486297">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fuhrman</surname><given-names>MP</given-names></name>
<name><surname>Charney</surname><given-names>P</given-names></name>
<name><surname>Mueller</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Hepatic proteins and nutrition assessment</article-title>. <source>J Am Diet Assoc</source>. <year>2004</year>;<volume>104</volume>(<issue>8</issue>):<fpage>1258</fpage>-<lpage>1264</lpage>.</citation>
</ref>
<ref id="bibr95-0884533613486297">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Banh</surname><given-names>L</given-names></name>
</person-group>. <article-title>Serum proteins as markers of nutrition: what are we treating?</article-title> <source>Pract Gastroenterol</source>. <year>2006</year>;<volume>43</volume>:<fpage>46</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr96-0884533613486297">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hart</surname><given-names>DW</given-names></name>
<name><surname>Wolf</surname><given-names>SE</given-names></name>
<name><surname>Herndon</surname><given-names>DN</given-names></name><etal/>
</person-group>. <article-title>Energy expenditure and caloric balance after burn: increased feeding leads to fat rather than lean mass accretion</article-title>. <source>Ann Surg</source>. <year>2002</year>;<volume>235</volume>:<fpage>152</fpage>-<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr97-0884533613486297">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Streat</surname><given-names>SJ</given-names></name>
<name><surname>Beddoe</surname><given-names>AH</given-names></name>
<name><surname>Hill</surname><given-names>GL</given-names></name>
</person-group>. <article-title>Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients</article-title>. <source>J Trauma</source>. <year>1987</year>;<volume>27</volume>:<fpage>262</fpage>-<lpage>266</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>